<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title> Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism - Middeldorp, S - 2014 | Cochrane Library</title> <meta content=" Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism - Middeldorp, S - 2014 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001367.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content=" Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism - Middeldorp, S - 2014 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001367.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD001367.pub3" name="dc.identifier" scheme="DOI"/> <meta content=" Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism" name="citation_title"/> <meta content="Saskia Middeldorp" name="citation_author"/> <meta content="Academic Medical Center" name="citation_author_institution"/> <meta content="Martin H Prins" name="citation_author"/> <meta content="CAPHRI Research School, Maastricht University" name="citation_author_institution"/> <meta content="Barbara A Hutten" name="citation_author"/> <meta content="Academic Medical Center" name="citation_author_institution"/> <meta content="b.a.hutten@amc.uva.nl" name="citation_author_email"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="8" name="citation_issue"/> <meta content="10.1002/14651858.CD001367.pub3" name="citation_doi"/> <meta content="2014" name="citation_date"/> <meta content="2014/08/05" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001367.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001367.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001367.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Anticoagulants [*administration &amp; dosage, adverse effects]; Drug Administration Schedule; Hemorrhage [chemically induced]; International Normalized Ratio; Randomized Controlled Trials as Topic; Secondary Prevention; Thromboembolism [*prevention &amp; control]; Time Factors; Venous Thrombosis [*prevention &amp; control]; Vitamin K [*antagonists &amp; inhibitors]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001367.pub3&amp;doi=10.1002/14651858.CD001367.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001367.pub3&amp;doi=10.1002/14651858.CD001367.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001367.pub3&amp;doi=10.1002/14651858.CD001367.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001367.pub3&amp;doi=10.1002/14651858.CD001367.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001367.pub3&amp;doi=10.1002/14651858.CD001367.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001367.pub3&amp;doi=10.1002/14651858.CD001367.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001367.pub3&amp;doi=10.1002/14651858.CD001367.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001367.pub3&amp;doi=10.1002/14651858.CD001367.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001367.pub3&amp;doi=10.1002/14651858.CD001367.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001367.pub3&amp;doi=10.1002/14651858.CD001367.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001367.pub3&amp;doi=10.1002/14651858.CD001367.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001367.pub3&amp;doi=10.1002/14651858.CD001367.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001367.pub3&amp;doi=10.1002/14651858.CD001367.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001367.pub3&amp;doi=10.1002/14651858.CD001367.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001367.pub3&amp;doi=10.1002/14651858.CD001367.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001367.pub3&amp;doi=10.1002/14651858.CD001367.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001367.pub3&amp;doi=10.1002/14651858.CD001367.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001367.pub3&amp;doi=10.1002/14651858.CD001367.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001367.pub3&amp;doi=10.1002/14651858.CD001367.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001367.pub3&amp;doi=10.1002/14651858.CD001367.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001367.pub3&amp;doi=10.1002/14651858.CD001367.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001367.pub3&amp;doi=10.1002/14651858.CD001367.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001367.pub3&amp;doi=10.1002/14651858.CD001367.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="afU96cMv";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD001367\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD001367\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001367\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001367\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","pt","hr","fr","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD001367.pub3",title:"\\n Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism",firstPublishedDate:"Aug 5, 2014 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Vascular Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=afU96cMv&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD001367.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD001367.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD001367.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD001367.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD001367.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD001367.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo para leigos&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]},{&quot;param&quot;: &quot;comments&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Comments&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD001367.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD001367.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD001367.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD001367.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>1398 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD001367.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001367.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001367.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001367.pub3/full#CD001367-abs-0005"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001367.pub3/full#CD001367-sec-0086"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001367.pub3/full#CD001367-sec-0029"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001367.pub3/full#CD001367-sec-0030"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001367.pub3/full#CD001367-sec-0034"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001367.pub3/full#CD001367-sec-0035"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001367.pub3/full#CD001367-sec-0058"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001367.pub3/full#CD001367-sec-0080"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001367.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001367.pub3/appendices#CD001367-sec-0091"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001367.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001367.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD001367.pub3/media/CDSR/CD001367/table_n/CD001367StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD001367.pub3/media/CDSR/CD001367/table_n/CD001367StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001367.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001367.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001367.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD001367.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD001367.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD001367.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2014 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en"> Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001367.pub3/information#CD001367-cr-0002">Saskia Middeldorp</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001367.pub3/information#CD001367-cr-0003">Martin H Prins</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001367.pub3/information#CD001367-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Barbara A Hutten</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/information/en#CD001367-sec-0099">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 05 August 2014 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD001367.pub3">https://doi.org/10.1002/14651858.CD001367.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD001367-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD001367-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD001367-abs-0004">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD001367-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD001367-abs-0003">Français</a> </li> <li class="section-language"> <a class="" href="full/pt#CD001367-abs-0002">Português</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD001367-abs-0001" lang="en"> <section id="CD001367-sec-0001"> <h3 class="title" id="CD001367-sec-0001">Background</h3> <p>Currently, the most frequently used secondary treatment for patients with venous thromboembolism (VTE) consists of vitamin K antagonists (VKA) targeted at an international normalized ratio (INR) of 2.5 (range 2.0 to 3.0). However, based on the continuing risk of bleeding and uncertainty regarding the risk of recurrent VTE, discussion on the proper duration of treatment with VKA for these patients is ongoing. Several studies have compared the risks and benefits of different durations of VKA in patients with VTE. This is the third update of a review first published in 2000. </p> </section> <section id="CD001367-sec-0002"> <h3 class="title" id="CD001367-sec-0002">Objectives</h3> <p>To evaluate the efficacy and safety of different durations of treatment with vitamin K antagonists in patients with symptomatic venous thromboembolism. </p> </section> <section id="CD001367-sec-0003"> <h3 class="title" id="CD001367-sec-0003">Search methods</h3> <p>For this update, the Cochrane Peripheral Vascular Diseases Group Trials Search Co‐ordinator searched the Specialised Register (last searched October 2013) and the Cochrane Central Register of Controlled Trials (CENTRAL) 2013, Issue 9. </p> </section> <section id="CD001367-sec-0004"> <h3 class="title" id="CD001367-sec-0004">Selection criteria</h3> <p>Randomized controlled clinical trials comparing different durations of treatment with vitamin K antagonists in patients with symptomatic venous thromboembolism. </p> </section> <section id="CD001367-sec-0005"> <h3 class="title" id="CD001367-sec-0005">Data collection and analysis</h3> <p>Three review authors (SM, MP, and BH) extracted the data and assessed the quality of the trials independently. </p> </section> <section id="CD001367-sec-0006"> <h3 class="title" id="CD001367-sec-0006">Main results</h3> <p>Eleven studies with a total of 3716 participants were included. A consistent and strong reduction in the risk of recurrent venous thromboembolic events was observed during prolonged treatment with VKA (risk ratio (RR) 0.20, 95% confidence interval (CI) 0.11 to 0.38) independent of the period elapsed since the index thrombotic event. A statistically significant "rebound" phenomenon (ie, an excess of recurrences shortly after cessation of prolonged treatment) was not found (RR 1.28, 95% CI 0.97 to 1.70). In addition, a substantial increase in bleeding complications was observed for patients receiving prolonged treatment during the entire period after randomization (RR 2.60, 95% CI 1.51 to 4.49). No reduction in mortality was noted during the entire study period (RR 0.89, 95% CI 0.66 to 1.21, P = 0.46). </p> </section> <section id="CD001367-sec-0007"> <h3 class="title" id="CD001367-sec-0007">Authors' conclusions</h3> <p>In conclusion, this review shows that treatment with VKA strongly reduces the risk of recurrent VTE for as long as they are used. However, the absolute risk of recurrent VTE declines over time, although the risk for major bleeding remains. Thus, the efficacy of VKA administration decreases over time since the index event. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD001367-abs-0005" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD001367-abs-0005">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD001367-abs-0009">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD001367-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD001367-abs-0008">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD001367-abs-0007">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/pt#CD001367-abs-0006">Português</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD001367-abs-0005" lang="en"> <h3>Length of treatment with vitamin K antagonists and prevention of recurrence in patients with venous thromboembolism </h3> <p>Venous thromboembolism (VTE) occurs when a blood clot is formed in a deep vein, or when it detaches itself and lodges in the lung vessels. These clots can be fatal if blood flow to the heart is blocked. Vitamin K antagonists (VKA) are given to people who have experienced a VTE, to prevent recurrence. The major complication of this treatment is bleeding. The continuing risk of bleeding with drug use and uncertainty regarding the extent of the risk of recurrence make it important to look at the proper duration of treatment with VKA for these patients. The review authors searched the literature and were able to combine data from 11 randomized controlled clinical trials (3716 participants) comparing different durations of treatment with VKA in patients with a symptomatic VTE. Participants receiving prolonged treatment had around five times lower risk of recurrence of VTE. On the other hand, they had about three times higher risk of bleeding complications. Prolonged treatment did not reduce the risk of death. Prolonged use of VKA strongly reduced the risk of recurrent clots as long as they were used, but benefit decreased over time and the risk of major bleeding remained. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD001367-sec-0086" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD001367-sec-0086"></div> <h3 class="title" id="CD001367-sec-0087">Implications for practice</h3> <section id="CD001367-sec-0087"> <p>This systematic review indicates that prolonged treatment with VKA reduces the risk of recurrent VTE for as long as they are used. However, lifelong treatment seems not to be indicated, in that efficacy during continuing treatment decreases, while the risk for major bleeding remains. </p> </section> <h3 class="title" id="CD001367-sec-0088">Implications for research</h3> <section id="CD001367-sec-0088"> <p>Further studies are required to determine for how long the duration of treatment with VKA should be extended. As patients have different risk profiles, the optimal duration will vary between specific groups. For this purpose, a decision analytic approach could be used by balancing benefit and risk on the basis of individual risk profiles. Furthermore, the expected increasing use of NOACs for prolonged treatment of VTE may modify the balance between recurrent VTE risk and bleeding. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD001367-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD001367-sec-0029"></div> <div class="table" id="CD001367-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Long‐term or short‐term treatment with vitamin K antagonists for patients with venous thromboembolism</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Long‐term or short‐term treatment with vitamin K antagonists for patients with venous thromboembolism</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with venous thromboembolism<br/> <b>Settings:</b> hospitals and medical centers<br/> <b>Intervention:</b> long‐term treatment with VKA<br/> <b>Comparison:</b> short‐term treatment with VKA </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Short‐term treatment with VKA</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Long‐term treatment with VKA</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Incidence of recurrent VTE</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>88 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>18 per 1000</b> <br/> (10 to 33) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.2</b> <br/> (0.11 to 0.38) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3536<br/> (10 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> <b>high</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Incidence of major bleeding</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>4 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>15 per 1000</b> <br/> (5 to 43) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 3.44</b> <br/> (1.22 to 9.74) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1350<br/> (6 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mortality</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>38 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>26 per 1000</b> <br/> (13 to 51) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.69</b> <br/> (0.35 to 1.34) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1049<br/> (4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (eg, the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence.<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Relatively wide 95% confidence interval around the estimate.<br/> <sup>2</sup>Only 4 studies (including 1 study without events) provided information on this outcome. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD001367-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD001367-sec-0030"></div> <section id="CD001367-sec-0031"> <h3 class="title" id="CD001367-sec-0031">Description of the condition</h3> <p>Venous thromboembolism (VTE), the collective term for deep venous thrombosis (DVT) and pulmonary embolism (PE), is a disorder that is frequently encountered in medical practice, affecting two to three of every 1000 persons (general population) per year. Venous thromboembolism may occur after surgery, after trauma and immobilization, in cancer patients, during hormonal contraceptive use or pregnancy, and after delivery (provoked), but it also occurs in the absence of such clinical risk factors (unprovoked). Hereditary thrombophilic conditions such as antithrombin, protein C, and protein S deficiencies, as well as Factor V Leiden and prothrombin 20210A mutations, increase the risk for both provoked and unprovoked venous thromboembolic events. </p> </section> <section id="CD001367-sec-0032"> <h3 class="title" id="CD001367-sec-0032">Description of the intervention</h3> <p>The most important aim of treatment for patients with VTE is to prevent recurrence, including potentially fatal PE. Patients are usually treated with an initial course of heparin or low‐molecular‐weight heparin (for approximately six days) associated with vitamin K antagonists (VKA) started simultaneously and continued for a period thereafter. This prolonged use of VKA has proven efficacy in comparison with placebo and low‐dose heparin (<a href="./references#CD001367-bbs2-0033" title="HullRD , DelmoreT , GentonE , HirshJ , GentM , SackettD , et al. Warfarin sodium versus low‐dose heparin in the long‐term treatment of venous thrombosis. New England Journal of Medicine1979;301(16):855‐8. ">Hull 1979</a>; <a href="./references#CD001367-bbs2-0020" title="LagerstedtCI , OlssonCG , FagherBO , OqvistBW , AlbrechtssonU . Need for long term anticoagulant treatment in symptomatic calf vein thrombosis. Lancet1985;2(8454):515‐8. ">Lagerstedt 1985</a>). The general consensus is that VKA should be targeted to prolongation of prothrombin time, compatible with an international normalized ratio (INR) of 2.0 to 3.0. </p> </section> <section id="CD001367-sec-0033"> <h3 class="title" id="CD001367-sec-0033">Why it is important to do this review</h3> <p>Based on the continuing risk of bleeding and uncertainty regarding the risk of recurrent VTE, discussion on the proper duration of oral anticoagulant treatment in patients with VTE is ongoing. Several studies have compared the risks and benefits of different durations of VKA treatment in patients with VTE. </p> <p>Therefore we evaluated in this review the reduction in the incidence of recurrent VTE and the excess of major bleeding associated with different durations of VKA in patients with VTE. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD001367-sec-0034" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD001367-sec-0034"></div> <p>To evaluate the efficacy and safety of different durations of treatment with vitamin K antagonists in patients with symptomatic venous thromboembolism. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD001367-sec-0035" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD001367-sec-0035"></div> <section id="CD001367-sec-0036"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD001367-sec-0037"> <h4 class="title">Types of studies</h4> <p>Studies in which participants were randomly allocated to different durations of VKA. Studies were excluded if they were duplicate reports or preliminary reports of data later presented in full. </p> </section> <section id="CD001367-sec-0038"> <h4 class="title">Types of participants</h4> <p>Studies were included if participants had symptomatic VTE. Studies were excluded if the trialists had not used accepted objective tests to confirm the diagnosis of DVT (eg, venography, ultrasonography) or PE (eg, high‐probability ventilation‐perfusion lung scan, pulmonary angiography). </p> </section> <section id="CD001367-sec-0039"> <h4 class="title">Types of interventions</h4> <p>Studies were included if different durations of treatment with a VKA, such as warfarin and acenocoumarol, were compared. Studies were excluded if different target INR ranges were used in the treatment arms, or if continuous use of another anticoagulant or antiplatelet drug was reported. </p> </section> <section id="CD001367-sec-0040"> <h4 class="title">Types of outcome measures</h4> <section id="CD001367-sec-0041"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD001367-list-0001"> <li> <p>Incidence of recurrent venous thromboembolism (DVT or PE).</p> </li> </ul> </p> </section> <section id="CD001367-sec-0042"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD001367-list-0002"> <li> <p>Incidence of major bleeding.</p> </li> <li> <p>Mortality.</p> </li> </ul> </p> <p>Studies were excluded if no data for thromboembolic events and bleeding were available, if outcome assessment was performed by assessors who were aware of study allocation, or if no breakdown was provided for minor and major bleeding. </p> <p>The following criteria were accepted for the diagnosis of recurrent symptomatic DVT: an extension of an intraluminal filling defect on a venogram; a new intraluminal filling defect or an extension of nonvisualization of proximal veins in the presence of a sudden cutoff defect on a venogram that was seen on at least two projections; if no previous venogram was available for comparison, an intraluminal filling defect; if no venogram was available, abnormal results of compression ultrasonography in an area where compression had been normal, or a substantial increase in the diameter of the thrombus during full compression at the popliteal or femoral vein (<a href="./references#CD001367-bbs2-0034" title="KoopmanMM , PrandoniP , PiovellaF , OckelfordPA , BrandjesDP , van derMeerJ , et al. The Tasman Study Group. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low‐molecular‐weight heparin administered at home. New England Journal of Medicine1996;334(11):682‐7. ">Koopman 1996</a>; <a href="./references#CD001367-bbs2-0035" title="LevineM , GentM , HirshJ , LeclercJ , AndersonD , WeitzJ , et al. A comparison of low‐molecular‐weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep‐vein thrombosis. New England Journal of Medicine1996;334(11):677‐81. ">Levine 1996</a>); or, if neither a venogram nor an ultrasonographic study was available, a change in the results of impedance plethysmography from normal to abnormal. </p> <p>The following criteria were accepted for the diagnosis of (recurrent) PE: a new intraluminal filling defect, an extension of an existing defect, or the sudden cutoff of vessels larger than 2.5 mm in diameter on a pulmonary angiogram; if no prior angiogram was available, an intraluminal filling defect or sudden cutoff of vessels larger than 2.5 mm in diameter on a pulmonary angiogram; or if no pulmonary angiogram was available, a defect of at least 75% of a segment on the perfusion scan, with normal ventilation. If the ventilation‐perfusion scan was nondiagnostic (and no pulmonary angiogram was available), satisfaction on the criteria for DVT was acceptable, or PE could be demonstrated at autopsy. </p> <p>Hemorrhages were classified as major if they were intracranial or retroperitoneal, led directly to death, necessitated transfusion, or led to interruption of antithrombotic treatment or (re)operation. All other hemorrhages were classified as nonmajor. </p> </section> </section> </section> <section id="CD001367-sec-0043"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD001367-sec-0044"> <h4 class="title">Electronic searches</h4> <p>For this update the Cochrane Peripheral Vascular Diseases Group Trials Search Co‐ordinator (TSC) searched the Specialised Register (last searched October 2013) and the Cochrane Central Register of Controlled Trials (CENTRAL) 2013, Issue 9, part of <i>The Cochrane Library</i>, (<a href="http://www.thecochranelibrary.com" target="_blank">www.thecochranelibrary.com</a>). See <a href="./appendices#CD001367-sec-0092">Appendix 1</a> for details of the search strategy used to search CENTRAL. The Specialised Register is maintained by the TSC and is constructed from weekly electronic searches of MEDLINE, EMBASE, CINAHL, AMED, and through handsearching relevant journals. The full list of the databases, journals and conference proceedings which have been searched, as well as the search strategies used are described in the <a href="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/PVD/frame.html" target="_blank">Specialised Register</a> section of the Cochrane Peripheral Vascular Diseases Group module in <i>The Cochrane Library</i> (<a href="http://www.thecochranelibrary.com" target="_blank">www.thecochranelibrary.com</a>). </p> </section> <section id="CD001367-sec-0045"> <h4 class="title">Searching other resources</h4> <p>Additional studies were sought by a manual search through reference lists of relevant studies and through personal communication with experts in the field. </p> </section> </section> <section id="CD001367-sec-0046"> <h3 class="title" id="CD001367-sec-0046">Data collection and analysis</h3> <section id="CD001367-sec-0047"> <h4 class="title">Selection of studies</h4> <p>Evaluation of potentially eligible studies to confirm eligibility and to assess methodological quality was performed independently by the three review authors (SM, MP, BH). Disagreements were resolved by discussion, and consensus was reached. </p> </section> <section id="CD001367-sec-0048"> <h4 class="title">Data extraction and management</h4> <p>Eligible articles were reviewed and summary information extracted. The following information was sought: participant characteristics (age, gender, comorbidity); number of participants in each treatment arm; duration, type, and intensity of VKA; incidence and timing of symptomatic recurrent VTE and major bleeding episodes; and mortality. </p> <p>Data were extracted independently by the three review authors (SM, MP, BH), using a standard form. Disagreements were resolved by discussion, and consensus was reached. </p> </section> <section id="CD001367-sec-0049"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>For this update, two review authors (SM, BH) independently assessed the risk of bias of each trial according to <a href="./references#CD001367-bbs2-0032" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions version 5.1.0. The Cochrane Collaboration, 2011. www.cochrane‐handbook.org. ">Higgins 2011</a> and based on the following domains: random sequence generation, allocation concealment, blinding (participants, care providers, or outcome assessors), incomplete outcome data, and other bias. For each of the domains, we assessed whether the study was at high risk of bias, low risk of bias, or unclear risk of bias by using the guidance provided by <a href="./references#CD001367-bbs2-0032" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions version 5.1.0. The Cochrane Collaboration, 2011. www.cochrane‐handbook.org. ">Higgins 2011</a>. Disagreements were resolved by discussion, and consensus was reached. </p> </section> <section id="CD001367-sec-0050"> <h4 class="title">Measures of treatment effect</h4> <p>The incidence of recurrent VTE, major bleeding, and mortality for the different treatment arms was used to calculate a risk ratio (RR) separately for each trial. Our outcomes were dichotomous, and we expressed results as RRs with 95% confidence intervals (CIs). </p> </section> <section id="CD001367-sec-0051"> <h4 class="title">Unit of analysis issues</h4> <p>The participant was the individual unit of analysis for all comparisons.</p> </section> <section id="CD001367-sec-0052"> <h4 class="title">Dealing with missing data</h4> <p>We analyzed available data (ie, while ignoring missing data).</p> </section> <section id="CD001367-sec-0053"> <h4 class="title">Assessment of heterogeneity</h4> <p>Heterogeneity of study results was evaluated using the Chi<sup>2</sup> test and I<sup>2</sup> statistic for each outcome separately. When the probability value of the Chi<sup>2</sup> test was &lt; 0.10 and/or the I<sup>2</sup> statistic was &gt; 40%, heterogeneity was considered significant. </p> </section> <section id="CD001367-sec-0054"> <h4 class="title">Assessment of reporting biases</h4> <p>To assess the risk of bias from selective reporting of outcomes, we searched in clinicaltrials.gov and controlled‐trials.com for a study protocol of each trial. If a study protocol was available, we evaluated whether all of the study's prespecified outcomes of interest in our review had been reported in the prespecified way in the final publication. </p> </section> <section id="CD001367-sec-0055"> <h4 class="title">Data synthesis</h4> <p>All data were analyzed by using the Review Manager software of The Cochrane Collaboration (<a href="./references#CD001367-bbs2-0042" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. The Nordic Cochrane Centre, The Cochrane Collaboration, 2012. ">RevMan 2012</a>). The incidence of recurrent VTE, major bleeding, and mortality for the different treatment arms was used to calculate an RR separately for each trial. These RRs were combined across studies, giving weight to the number of events in each of the two treatment groups in each separate study, using the Mantel‐Haenszel procedure, which assumes a fixed treatment effect (<a href="./references#CD001367-bbs2-0030" title="CollinsR , Gray , GodwinJ , PetaR . Avoidance of large biases and large random errors in the assessment of moderate treatment effects: the need for systematic overviews. Statistics in Medicine1987;6(3):245‐50. ">Collins 1987</a>; <a href="./references#CD001367-bbs2-0037" title="MantelN , HaenszelW . Statistical aspects of the analysis of data from retrospective studies of disease. Journal of the National Cancer Institute1959;22:719‐48. ">Mantel 1959</a>; <a href="./references#CD001367-bbs2-0045" title="YusufS , PetoR , LewisJ , CollinsR , SleightP . Beta blockade during and after myocardial infarction: an overview of the randomized trials. Progress in Cardiovascular Diseases1985;27(5):335‐71. ">Yusuf 1985</a>). </p> <p>The advisability of combining the trials was addressed by performing a statistical test of heterogeneity, which considers whether differences in treatment effect over individual trials are consistent with natural variation around a constant effect (<a href="./references#CD001367-bbs2-0030" title="CollinsR , Gray , GodwinJ , PetaR . Avoidance of large biases and large random errors in the assessment of moderate treatment effects: the need for systematic overviews. Statistics in Medicine1987;6(3):245‐50. ">Collins 1987</a>). In addition, qualitative assessment of heterogeneity was performed if indicated. When the probability value of the Chi<sup>2</sup> test was &lt; 0.10 and/or I<sup>2</sup> was &gt; 40%, heterogeneity was considered significant. In cases of significant heterogeneity, data from the studies were combined using a random‐effects model according to the method of DerSimonian and Laird. A Z‐test was performed to test the overall effect. If no significant heterogeneity was observed, studies were combined by using a fixed‐effect model. </p> <p>Analyses were performed separately for:</p> <p> <ul id="CD001367-list-0003"> <li> <p>the period from VKA cessation in the shorter duration arm until VKA cessation in the longer duration arm; </p> </li> <li> <p>the period after cessation of study medication until the end of follow‐up;</p> </li> <li> <p>the entire period after randomization reported in the publication;</p> </li> <li> <p>if available in more than one study, comparisons of two specific durations (eg, six weeks vs six months) of VKA use; </p> </li> <li> <p>studies with adequately concealed randomization; and</p> </li> <li> <p>studies without missing values.</p> </li> </ul> </p> </section> <section id="CD001367-sec-0056"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>If we identified substantial heterogeneity (ie, I<sup>2</sup> &gt; 60%), we performed subgroup analyses to explore heterogeneity. </p> </section> <section id="CD001367-sec-0057"> <h4 class="title">Sensitivity analysis</h4> <p>To determine whether conclusions were robust to decisions made during the review process, we performed analyses separately for studies with adequate randomization and for studies in which none of the participants dropped out or were lost‐to‐follow up, for the period from cessation of treatment with VKA in the short duration arm until cessation of treatment in the long duration arm. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD001367-sec-0058" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD001367-sec-0058"></div> <section id="CD001367-sec-0059"> <h3 class="title">Description of studies</h3> <section id="CD001367-sec-0060"> <h4 class="title">Results of the search</h4> <p>See <a href="#CD001367-fig-0001">Figure 1</a>. </p> <div class="figure" id="CD001367-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD001367-fig-0001" src="/cdsr/doi/10.1002/14651858.CD001367.pub3/media/CDSR/CD001367/image_n/nCD001367-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD001367-sec-0061"> <h4 class="title">Included studies</h4> <p>Three additional studies were included in this update (<a href="./references#CD001367-bbs2-0003" title="EischerL , GartnerV , SchulmanS , KyrlePA , EichingerS . 6 versus 30 months anticoagulation for recurrent venous thrombosis in patients with high factor VIII. Annals of Hematology2009;88:485‐90. ">Eischer 2009</a>; <a href="./references#CD001367-bbs2-0008" title="RidkerP , GoldhaberS , GlynnR . Long‐term, low‐intensity warfarin for the prevention of recurrent venous thromboembolism: the PREVENT trial. Journal of Thrombosis and Haemostasis2003; Vol. 1, issue Suppl 1:Abstract OC001. RidkerPM , GoldhaberSZ , DanielsonE , RosenbergY , EbyCS , DeitcherSR , et al. Long‐term, low‐intensity warfarin therapy for the prevention of recurrent venous thromboembolism. New England Journal of Medicine2003;348(15):1425‐34. ">Ridker 2003</a>; <a href="./references#CD001367-bbs2-0011" title="SiragusaS , MalatoA , AnastasioR , CignaV , MilioG , AmatoC , et al. Residual vein thrombosis to establish duration of anticoagulation after a first episode of deep vein thrombosis: the Duration of Anticoagulation based on Compression Ultrasound (DACUS) study. Blood2008;112(3):511‐5. ">Siragusa 2008</a>), making a total of 11 included studies (<a href="./references#CD001367-bbs2-0001" title="AgnelliG , PrandoniP , SantamariaMG , BagatellaP , IorioA , BazzanM , et al. Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. New England Journal of Medicine2001;345(3):165‐9. ">Agnelli 2001</a>; <a href="./references#CD001367-bbs2-0002" title="AgnelliG , PrandoniP , BecattiniC , SilingardiM , TalianiMR , MiccioM , et al. Extended oral anticoagulant therapy after first episode of pulmonary embolism. Annals of Internal Medicine2003;139(1):19‐25. ">Agnelli 2003</a>; <a href="./references#CD001367-bbs2-0003" title="EischerL , GartnerV , SchulmanS , KyrlePA , EichingerS . 6 versus 30 months anticoagulation for recurrent venous thrombosis in patients with high factor VIII. Annals of Hematology2009;88:485‐90. ">Eischer 2009</a>; <a href="./references#CD001367-bbs2-0004" title="KearonC , GentM , HirshJ , WeitzJ , KovacsMJ , AndersonDR , et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. New England Journal of Medicine1999;340(12):901‐7. ">Kearon 1999</a>; <a href="./references#CD001367-bbs2-0005" title="KearonC , GinsbergJS , AndersonDR , KovacsMJ , WellsP , JulianJA , et al. Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor. Journal of Thrombosis and Haemostasis2004;2:743‐9. ">Kearon 2004</a>; <a href="./references#CD001367-bbs2-0006" title="LevineMN , HirshJ , GentM , TurpieAG , WeitzJ , GinsbergJ , et al. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis. Thrombosis and Haemostasis1995;74(2):606‐11. LevineMN , HirshJ , GentM , TurpieAG , WeitzJ , GinsburgJ , et al. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis (DVT). Thrombosis and Haemostasis1993; Vol. 69, issue 6:982. Abstract No 1581. ">Levine 1995</a>; <a href="./references#CD001367-bbs2-0007" title="PinedeL , NinetJ , DuhautP , ChabaudS , Demolombe‐RagueS , DurieuI , et al. Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis. Circulation2001;103(20):2453‐60. ">Pinede 2001</a>; <a href="./references#CD001367-bbs2-0008" title="RidkerP , GoldhaberS , GlynnR . Long‐term, low‐intensity warfarin for the prevention of recurrent venous thromboembolism: the PREVENT trial. Journal of Thrombosis and Haemostasis2003; Vol. 1, issue Suppl 1:Abstract OC001. RidkerPM , GoldhaberSZ , DanielsonE , RosenbergY , EbyCS , DeitcherSR , et al. Long‐term, low‐intensity warfarin therapy for the prevention of recurrent venous thromboembolism. New England Journal of Medicine2003;348(15):1425‐34. ">Ridker 2003</a>; <a href="./references#CD001367-bbs2-0009" title="SchulmanS , RhedinA‐S , LindmarkerP , CarlssonA , LarfarsG , NicolP , et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. New England Journal of Medicine1995;332(25):1661‐5. ">Schulman 1995</a>; <a href="./references#CD001367-bbs2-0010" title="SchulmanS , GranqvistS , HolmstromM , CarlssonA , LindmarkerP , NicolP , et al. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. New England Journal of Medicine1997;336(6):393‐8. ">Schulman 1997</a>; <a href="./references#CD001367-bbs2-0011" title="SiragusaS , MalatoA , AnastasioR , CignaV , MilioG , AmatoC , et al. Residual vein thrombosis to establish duration of anticoagulation after a first episode of deep vein thrombosis: the Duration of Anticoagulation based on Compression Ultrasound (DACUS) study. Blood2008;112(3):511‐5. ">Siragusa 2008</a>), which were published between 1995 and 2009 with a total of 3716 participants. In seven studies (<a href="./references#CD001367-bbs2-0001" title="AgnelliG , PrandoniP , SantamariaMG , BagatellaP , IorioA , BazzanM , et al. Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. New England Journal of Medicine2001;345(3):165‐9. ">Agnelli 2001</a>, <a href="./references#CD001367-bbs2-0002" title="AgnelliG , PrandoniP , BecattiniC , SilingardiM , TalianiMR , MiccioM , et al. Extended oral anticoagulant therapy after first episode of pulmonary embolism. Annals of Internal Medicine2003;139(1):19‐25. ">Agnelli 2003</a>, <a href="./references#CD001367-bbs2-0003" title="EischerL , GartnerV , SchulmanS , KyrlePA , EichingerS . 6 versus 30 months anticoagulation for recurrent venous thrombosis in patients with high factor VIII. Annals of Hematology2009;88:485‐90. ">Eischer 2009</a>, <a href="./references#CD001367-bbs2-0004" title="KearonC , GentM , HirshJ , WeitzJ , KovacsMJ , AndersonDR , et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. New England Journal of Medicine1999;340(12):901‐7. ">Kearon 1999</a>, <a href="./references#CD001367-bbs2-0005" title="KearonC , GinsbergJS , AndersonDR , KovacsMJ , WellsP , JulianJA , et al. Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor. Journal of Thrombosis and Haemostasis2004;2:743‐9. ">Kearon 2004</a>, <a href="./references#CD001367-bbs2-0009" title="SchulmanS , RhedinA‐S , LindmarkerP , CarlssonA , LarfarsG , NicolP , et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. New England Journal of Medicine1995;332(25):1661‐5. ">Schulman 1995</a>, <a href="./references#CD001367-bbs2-0011" title="SiragusaS , MalatoA , AnastasioR , CignaV , MilioG , AmatoC , et al. Residual vein thrombosis to establish duration of anticoagulation after a first episode of deep vein thrombosis: the Duration of Anticoagulation based on Compression Ultrasound (DACUS) study. Blood2008;112(3):511‐5. ">Siragusa 2008</a>), participants with a first episode of VTE (ie, DVT,PE, or both) were included. Of these studies, <a href="./references#CD001367-bbs2-0003" title="EischerL , GartnerV , SchulmanS , KyrlePA , EichingerS . 6 versus 30 months anticoagulation for recurrent venous thrombosis in patients with high factor VIII. Annals of Hematology2009;88:485‐90. ">Eischer 2009</a> included only participants with levels of FVIII above 230 IU/dL, and <a href="./references#CD001367-bbs2-0011" title="SiragusaS , MalatoA , AnastasioR , CignaV , MilioG , AmatoC , et al. Residual vein thrombosis to establish duration of anticoagulation after a first episode of deep vein thrombosis: the Duration of Anticoagulation based on Compression Ultrasound (DACUS) study. Blood2008;112(3):511‐5. ">Siragusa 2008</a> included participants with residual vein thrombosis. In the study of <a href="./references#CD001367-bbs2-0010" title="SchulmanS , GranqvistS , HolmstromM , CarlssonA , LindmarkerP , NicolP , et al. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. New England Journal of Medicine1997;336(6):393‐8. ">Schulman 1997</a>, participants with a second episode of VTE were included, and in the other two studies (<a href="./references#CD001367-bbs2-0006" title="LevineMN , HirshJ , GentM , TurpieAG , WeitzJ , GinsbergJ , et al. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis. Thrombosis and Haemostasis1995;74(2):606‐11. LevineMN , HirshJ , GentM , TurpieAG , WeitzJ , GinsburgJ , et al. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis (DVT). Thrombosis and Haemostasis1993; Vol. 69, issue 6:982. Abstract No 1581. ">Levine 1995</a>; <a href="./references#CD001367-bbs2-0007" title="PinedeL , NinetJ , DuhautP , ChabaudS , Demolombe‐RagueS , DurieuI , et al. Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis. Circulation2001;103(20):2453‐60. ">Pinede 2001</a>), participants with acute proximal DVT were included. For the study of <a href="./references#CD001367-bbs2-0008" title="RidkerP , GoldhaberS , GlynnR . Long‐term, low‐intensity warfarin for the prevention of recurrent venous thromboembolism: the PREVENT trial. Journal of Thrombosis and Haemostasis2003; Vol. 1, issue Suppl 1:Abstract OC001. RidkerPM , GoldhaberSZ , DanielsonE , RosenbergY , EbyCS , DeitcherSR , et al. Long‐term, low‐intensity warfarin therapy for the prevention of recurrent venous thromboembolism. New England Journal of Medicine2003;348(15):1425‐34. ">Ridker 2003</a>, it was unclear whether participants with a first or second episode of VTE were included. In all studies, objective diagnostic tests were used to confirm the diagnosis. </p> <p>The 11 studies compared the following different periods of treatment with VKA: four weeks versus three months (<a href="./references#CD001367-bbs2-0005" title="KearonC , GinsbergJS , AndersonDR , KovacsMJ , WellsP , JulianJA , et al. Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor. Journal of Thrombosis and Haemostasis2004;2:743‐9. ">Kearon 2004</a>; <a href="./references#CD001367-bbs2-0006" title="LevineMN , HirshJ , GentM , TurpieAG , WeitzJ , GinsbergJ , et al. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis. Thrombosis and Haemostasis1995;74(2):606‐11. LevineMN , HirshJ , GentM , TurpieAG , WeitzJ , GinsburgJ , et al. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis (DVT). Thrombosis and Haemostasis1993; Vol. 69, issue 6:982. Abstract No 1581. ">Levine 1995</a>), six weeks versus 12 weeks (<a href="./references#CD001367-bbs2-0007" title="PinedeL , NinetJ , DuhautP , ChabaudS , Demolombe‐RagueS , DurieuI , et al. Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis. Circulation2001;103(20):2453‐60. ">Pinede 2001</a>), six weeks versus six months (<a href="./references#CD001367-bbs2-0009" title="SchulmanS , RhedinA‐S , LindmarkerP , CarlssonA , LarfarsG , NicolP , et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. New England Journal of Medicine1995;332(25):1661‐5. ">Schulman 1995</a>), three months versus six months (<a href="./references#CD001367-bbs2-0002" title="AgnelliG , PrandoniP , BecattiniC , SilingardiM , TalianiMR , MiccioM , et al. Extended oral anticoagulant therapy after first episode of pulmonary embolism. Annals of Internal Medicine2003;139(1):19‐25. ">Agnelli 2003</a>, <a href="./references#CD001367-bbs2-0007" title="PinedeL , NinetJ , DuhautP , ChabaudS , Demolombe‐RagueS , DurieuI , et al. Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis. Circulation2001;103(20):2453‐60. ">Pinede 2001</a>), three months versus one year (<a href="./references#CD001367-bbs2-0001" title="AgnelliG , PrandoniP , SantamariaMG , BagatellaP , IorioA , BazzanM , et al. Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. New England Journal of Medicine2001;345(3):165‐9. ">Agnelli 2001</a>; <a href="./references#CD001367-bbs2-0011" title="SiragusaS , MalatoA , AnastasioR , CignaV , MilioG , AmatoC , et al. Residual vein thrombosis to establish duration of anticoagulation after a first episode of deep vein thrombosis: the Duration of Anticoagulation based on Compression Ultrasound (DACUS) study. Blood2008;112(3):511‐5. ">Siragusa 2008</a>), three months versus 27 months (<a href="./references#CD001367-bbs2-0004" title="KearonC , GentM , HirshJ , WeitzJ , KovacsMJ , AndersonDR , et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. New England Journal of Medicine1999;340(12):901‐7. ">Kearon 1999</a>), four months versus 27 months (<a href="./references#CD001367-bbs2-0008" title="RidkerP , GoldhaberS , GlynnR . Long‐term, low‐intensity warfarin for the prevention of recurrent venous thromboembolism: the PREVENT trial. Journal of Thrombosis and Haemostasis2003; Vol. 1, issue Suppl 1:Abstract OC001. RidkerPM , GoldhaberSZ , DanielsonE , RosenbergY , EbyCS , DeitcherSR , et al. Long‐term, low‐intensity warfarin therapy for the prevention of recurrent venous thromboembolism. New England Journal of Medicine2003;348(15):1425‐34. ">Ridker 2003</a>), six months versus 30 months (<a href="./references#CD001367-bbs2-0003" title="EischerL , GartnerV , SchulmanS , KyrlePA , EichingerS . 6 versus 30 months anticoagulation for recurrent venous thrombosis in patients with high factor VIII. Annals of Hematology2009;88:485‐90. ">Eischer 2009</a>), and six months versus four years (<a href="./references#CD001367-bbs2-0010" title="SchulmanS , GranqvistS , HolmstromM , CarlssonA , LindmarkerP , NicolP , et al. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. New England Journal of Medicine1997;336(6):393‐8. ">Schulman 1997</a>). For details of these studies, see the <a href="./references#CD001367-sec-0105" title="">Characteristics of included studies</a> section. </p> </section> <section id="CD001367-sec-0062"> <h4 class="title">Excluded studies</h4> <p>For this update, seven additional studies were excluded (<a href="./references#CD001367-bbs2-0012" title="AgrawalN , KumarS , SinghK , SinghG , SharmaS , SethT , et al. Study of duration of anticoagulation in patients with deep vein thrombosis based on compression ultrasound. Indian Journal of Hematology and Blood Transfusion2011;27:230. ">Agrawal 2011</a>; <a href="./references#CD001367-bbs2-0013" title="AscaniA , IorioA , AgnelliG . Withdrawal of warfarin after deep vein thrombosis: effects of a low fixed dose on rebound thrombin generation. Blood Coagulation and Fibrinolysis1999;10:291‐5. AscaniA , IorioA , StabileAM , AgnelliG . Withdrawal of warfarin therapy after deep vein thrombosis: a randomised study on the effects of a very low fixed dose regimen. Thrombosis and Haemostasis1997, issue Suppl 8 June:83. Abstract No PS‐335. ">Ascani 1999</a>; <a href="./references#CD001367-bbs2-0014" title="CampbellIA , BentleyDP , PrescottRJ , RoutledgePA , ShettyHG , WilliamsonIJ . Anticoagulation for three versus six months in patients with deep vein thrombosis or pulmonary embolism, or both: randomised trial. BMJ2007;334(7595):674. NCT00365950 . 3 months' versus 6 months' anticoagulation in patients with DVT. http://clinicaltrial.gov/show/NCT00365950 (accessed 22 April 2014). ">Campbell 2007</a>; <a href="./references#CD001367-bbs2-0016" title="FarrajRS . Anticoagulation period in idiopathic venous thromboembolism. How long is enough?. Saudi Medical Journal2004;25(7):848‐51. ">Farraj 2004</a>; <a href="./references#CD001367-bbs2-0018" title="FerraraF , MeliF , AmatoC , CospiteV , RaimondiF , NovoG , et al. Optimal duration of treatment in surgical patients with calf venous thrombosis involving one or more veins. Angiology2006;57(4):418‐23. ">Ferrara 2006</a>; <a href="./references#CD001367-bbs2-0022" title="PalaretiG , CosmiB , LegnaniC , TosettoA , BrusiC , IorioA , et al. D‐dimer testing to determine the duration of anticoagulation therapy. New England Journal of Medicine2006;355(17):1780‐9. ">Palareti 2006</a>; <a href="./references#CD001367-bbs2-0023" title="PrandoniP , PrinsMH , LensingAW , GhirarduzziA , AgenoW , ImbertiD , et al. Residual thrombosis on ultrasonography to guide the duration of anticoagulation in patients with deep venous thrombosis: a randomized trial. Annals of Internal Medicine2009;150(9):577‐85. ">Prandoni 2009</a>), making a total of 14 excluded studies (<a href="./references#CD001367-bbs2-0012" title="AgrawalN , KumarS , SinghK , SinghG , SharmaS , SethT , et al. Study of duration of anticoagulation in patients with deep vein thrombosis based on compression ultrasound. Indian Journal of Hematology and Blood Transfusion2011;27:230. ">Agrawal 2011</a>; <a href="./references#CD001367-bbs2-0013" title="AscaniA , IorioA , AgnelliG . Withdrawal of warfarin after deep vein thrombosis: effects of a low fixed dose on rebound thrombin generation. Blood Coagulation and Fibrinolysis1999;10:291‐5. AscaniA , IorioA , StabileAM , AgnelliG . Withdrawal of warfarin therapy after deep vein thrombosis: a randomised study on the effects of a very low fixed dose regimen. Thrombosis and Haemostasis1997, issue Suppl 8 June:83. Abstract No PS‐335. ">Ascani 1999</a>; <a href="./references#CD001367-bbs2-0014" title="CampbellIA , BentleyDP , PrescottRJ , RoutledgePA , ShettyHG , WilliamsonIJ . Anticoagulation for three versus six months in patients with deep vein thrombosis or pulmonary embolism, or both: randomised trial. BMJ2007;334(7595):674. NCT00365950 . 3 months' versus 6 months' anticoagulation in patients with DVT. http://clinicaltrial.gov/show/NCT00365950 (accessed 22 April 2014). ">Campbell 2007</a>; <a href="./references#CD001367-bbs2-0015" title="DrouetL , BossonJL , LanoyeP , Dutrey‐DupagneC , GenceD . A prospective randomized study to assess the usefulness of venous compression ultrasonography (CUS) and plasma d‐dimer (DD) assay in the decision to discontinue treatment with a vitamin K antagonists (VKA) after an acute deep‐vein thrombosis (DVT). Presented at XIX Congress of the International Society on Thrombosis and Haemostasis. Journal of Thrombosis and Haemostasis. 2003 (Suppl 1):Abstract P1952. ">Drouet 2003</a>; <a href="./references#CD001367-bbs2-0016" title="FarrajRS . Anticoagulation period in idiopathic venous thromboembolism. How long is enough?. Saudi Medical Journal2004;25(7):848‐51. ">Farraj 2004</a>; <a href="./references#CD001367-bbs2-0017" title="FennertyAG , DolbenJ , ThomasP , BackhouseG , BentleyDP , CampbellIA , et al. A comparison of 3 and 6 weeks' anticoagulation in the treatment of venous thromboembolism. Clinical and Laboratory Haematology1987;9(1):17‐21. ">Fennerty 1987</a>; <a href="./references#CD001367-bbs2-0018" title="FerraraF , MeliF , AmatoC , CospiteV , RaimondiF , NovoG , et al. Optimal duration of treatment in surgical patients with calf venous thrombosis involving one or more veins. Angiology2006;57(4):418‐23. ">Ferrara 2006</a>; <a href="./references#CD001367-bbs2-0019" title="AnderssonG , FagrellB , HolmgrenK , JohnssonH , LjungbergB , WilhelmssonS . Antithrombin III in patients with acute deep vein thrombosis during heparin treatment (subcutaneous and intravenous) and during and after treatment with oral coumarins. Thrombosis Research1984;34(4):333‐40. HolmgrenK , AnderssonG , FagrellB , JohnssonH , LjungbergB , NilssonE , et al. One month versus six months therapy with oral anticoagulants after symptomatic deep‐vein thrombosis. Thrombosis and Haemostasis1983; Vol. 50, issue 1:310. Abstract No. 0987. HolmgrenK , AnderssonG , FagrellB , JohnssonH , LjungbergB , NilssonE , et al. One‐month versus six‐month therapy with oral anticoagulants after symptomatic deep vein thrombosis. Acta Medica Scandinavica1985;218(3):279‐84. ">Holmgren 1985</a>; <a href="./references#CD001367-bbs2-0020" title="LagerstedtCI , OlssonCG , FagherBO , OqvistBW , AlbrechtssonU . Need for long term anticoagulant treatment in symptomatic calf vein thrombosis. Lancet1985;2(8454):515‐8. ">Lagerstedt 1985</a>; <a href="./references#CD001367-bbs2-0021" title="O'SullivanEF . Duration of anticoagulant therapy in venous thrombo‐embolism. Medical Journal of Australia1972;2(20):1104‐7. ">O'Sullivan 1972</a>; <a href="./references#CD001367-bbs2-0022" title="PalaretiG , CosmiB , LegnaniC , TosettoA , BrusiC , IorioA , et al. D‐dimer testing to determine the duration of anticoagulation therapy. New England Journal of Medicine2006;355(17):1780‐9. ">Palareti 2006</a>; <a href="./references#CD001367-bbs2-0023" title="PrandoniP , PrinsMH , LensingAW , GhirarduzziA , AgenoW , ImbertiD , et al. Residual thrombosis on ultrasonography to guide the duration of anticoagulation in patients with deep venous thrombosis: a randomized trial. Annals of Internal Medicine2009;150(9):577‐85. ">Prandoni 2009</a>; <a href="./references#CD001367-bbs2-0024" title="SchulmanS , LocknerD , Juhlin‐DannfeltA . The duration of oral anticoagulation after deep vein thrombosis. A randomized study. Acta Medica Scandinavica1985;217(5):547‐52. ">Schulman 1985</a>; <a href="./references#CD001367-bbs2-0025" title="SudlowMF , CampbellIA , AngelJH , BentleyDP , FennertyAG , PrescottRJ , et al. Optimum duration of anticoagulation for deep‐vein thrombosis and pulmonary embolism. Lancet1992;340(8824):873‐6. ">Sudlow 1992</a>). Studies were excluded for the following reasons (some studies were excluded for more than one reason): no objective tests used to confirm VTE for all participants (<a href="./references#CD001367-bbs2-0014" title="CampbellIA , BentleyDP , PrescottRJ , RoutledgePA , ShettyHG , WilliamsonIJ . Anticoagulation for three versus six months in patients with deep vein thrombosis or pulmonary embolism, or both: randomised trial. BMJ2007;334(7595):674. NCT00365950 . 3 months' versus 6 months' anticoagulation in patients with DVT. http://clinicaltrial.gov/show/NCT00365950 (accessed 22 April 2014). ">Campbell 2007</a>; <a href="./references#CD001367-bbs2-0017" title="FennertyAG , DolbenJ , ThomasP , BackhouseG , BentleyDP , CampbellIA , et al. A comparison of 3 and 6 weeks' anticoagulation in the treatment of venous thromboembolism. Clinical and Laboratory Haematology1987;9(1):17‐21. ">Fennerty 1987</a>; <a href="./references#CD001367-bbs2-0019" title="AnderssonG , FagrellB , HolmgrenK , JohnssonH , LjungbergB , WilhelmssonS . Antithrombin III in patients with acute deep vein thrombosis during heparin treatment (subcutaneous and intravenous) and during and after treatment with oral coumarins. Thrombosis Research1984;34(4):333‐40. HolmgrenK , AnderssonG , FagrellB , JohnssonH , LjungbergB , NilssonE , et al. One month versus six months therapy with oral anticoagulants after symptomatic deep‐vein thrombosis. Thrombosis and Haemostasis1983; Vol. 50, issue 1:310. Abstract No. 0987. HolmgrenK , AnderssonG , FagrellB , JohnssonH , LjungbergB , NilssonE , et al. One‐month versus six‐month therapy with oral anticoagulants after symptomatic deep vein thrombosis. Acta Medica Scandinavica1985;218(3):279‐84. ">Holmgren 1985</a>; <a href="./references#CD001367-bbs2-0021" title="O'SullivanEF . Duration of anticoagulant therapy in venous thrombo‐embolism. Medical Journal of Australia1972;2(20):1104‐7. ">O'Sullivan 1972</a>; <a href="./references#CD001367-bbs2-0025" title="SudlowMF , CampbellIA , AngelJH , BentleyDP , FennertyAG , PrescottRJ , et al. Optimum duration of anticoagulation for deep‐vein thrombosis and pulmonary embolism. Lancet1992;340(8824):873‐6. ">Sudlow 1992</a>); no blinded or partly blinded outcome assessment or unclear whether blinded outcome measurement was used (<a href="./references#CD001367-bbs2-0012" title="AgrawalN , KumarS , SinghK , SinghG , SharmaS , SethT , et al. Study of duration of anticoagulation in patients with deep vein thrombosis based on compression ultrasound. Indian Journal of Hematology and Blood Transfusion2011;27:230. ">Agrawal 2011</a>; <a href="./references#CD001367-bbs2-0014" title="CampbellIA , BentleyDP , PrescottRJ , RoutledgePA , ShettyHG , WilliamsonIJ . Anticoagulation for three versus six months in patients with deep vein thrombosis or pulmonary embolism, or both: randomised trial. BMJ2007;334(7595):674. NCT00365950 . 3 months' versus 6 months' anticoagulation in patients with DVT. http://clinicaltrial.gov/show/NCT00365950 (accessed 22 April 2014). ">Campbell 2007</a>; <a href="./references#CD001367-bbs2-0015" title="DrouetL , BossonJL , LanoyeP , Dutrey‐DupagneC , GenceD . A prospective randomized study to assess the usefulness of venous compression ultrasonography (CUS) and plasma d‐dimer (DD) assay in the decision to discontinue treatment with a vitamin K antagonists (VKA) after an acute deep‐vein thrombosis (DVT). Presented at XIX Congress of the International Society on Thrombosis and Haemostasis. Journal of Thrombosis and Haemostasis. 2003 (Suppl 1):Abstract P1952. ">Drouet 2003</a>; <a href="./references#CD001367-bbs2-0016" title="FarrajRS . Anticoagulation period in idiopathic venous thromboembolism. How long is enough?. Saudi Medical Journal2004;25(7):848‐51. ">Farraj 2004</a>; <a href="./references#CD001367-bbs2-0017" title="FennertyAG , DolbenJ , ThomasP , BackhouseG , BentleyDP , CampbellIA , et al. A comparison of 3 and 6 weeks' anticoagulation in the treatment of venous thromboembolism. Clinical and Laboratory Haematology1987;9(1):17‐21. ">Fennerty 1987</a>; <a href="./references#CD001367-bbs2-0018" title="FerraraF , MeliF , AmatoC , CospiteV , RaimondiF , NovoG , et al. Optimal duration of treatment in surgical patients with calf venous thrombosis involving one or more veins. Angiology2006;57(4):418‐23. ">Ferrara 2006</a>; <a href="./references#CD001367-bbs2-0019" title="AnderssonG , FagrellB , HolmgrenK , JohnssonH , LjungbergB , WilhelmssonS . Antithrombin III in patients with acute deep vein thrombosis during heparin treatment (subcutaneous and intravenous) and during and after treatment with oral coumarins. Thrombosis Research1984;34(4):333‐40. HolmgrenK , AnderssonG , FagrellB , JohnssonH , LjungbergB , NilssonE , et al. One month versus six months therapy with oral anticoagulants after symptomatic deep‐vein thrombosis. Thrombosis and Haemostasis1983; Vol. 50, issue 1:310. Abstract No. 0987. HolmgrenK , AnderssonG , FagrellB , JohnssonH , LjungbergB , NilssonE , et al. One‐month versus six‐month therapy with oral anticoagulants after symptomatic deep vein thrombosis. Acta Medica Scandinavica1985;218(3):279‐84. ">Holmgren 1985</a>; <a href="./references#CD001367-bbs2-0020" title="LagerstedtCI , OlssonCG , FagherBO , OqvistBW , AlbrechtssonU . Need for long term anticoagulant treatment in symptomatic calf vein thrombosis. Lancet1985;2(8454):515‐8. ">Lagerstedt 1985</a>; <a href="./references#CD001367-bbs2-0021" title="O'SullivanEF . Duration of anticoagulant therapy in venous thrombo‐embolism. Medical Journal of Australia1972;2(20):1104‐7. ">O'Sullivan 1972</a>; <a href="./references#CD001367-bbs2-0024" title="SchulmanS , LocknerD , Juhlin‐DannfeltA . The duration of oral anticoagulation after deep vein thrombosis. A randomized study. Acta Medica Scandinavica1985;217(5):547‐52. ">Schulman 1985</a>; <a href="./references#CD001367-bbs2-0025" title="SudlowMF , CampbellIA , AngelJH , BentleyDP , FennertyAG , PrescottRJ , et al. Optimum duration of anticoagulation for deep‐vein thrombosis and pulmonary embolism. Lancet1992;340(8824):873‐6. ">Sudlow 1992</a>); INR target range not the same in the treatment arms (<a href="./references#CD001367-bbs2-0013" title="AscaniA , IorioA , AgnelliG . Withdrawal of warfarin after deep vein thrombosis: effects of a low fixed dose on rebound thrombin generation. Blood Coagulation and Fibrinolysis1999;10:291‐5. AscaniA , IorioA , StabileAM , AgnelliG . Withdrawal of warfarin therapy after deep vein thrombosis: a randomised study on the effects of a very low fixed dose regimen. Thrombosis and Haemostasis1997, issue Suppl 8 June:83. Abstract No PS‐335. ">Ascani 1999</a>); duration of VKA in one arm tailored on the basis of ultrasonography findings (flexible duration) (<a href="./references#CD001367-bbs2-0023" title="PrandoniP , PrinsMH , LensingAW , GhirarduzziA , AgenoW , ImbertiD , et al. Residual thrombosis on ultrasonography to guide the duration of anticoagulation in patients with deep venous thrombosis: a randomized trial. Annals of Internal Medicine2009;150(9):577‐85. ">Prandoni 2009</a>); and discontinuation of treatment by all participants for one month before randomization (<a href="./references#CD001367-bbs2-0022" title="PalaretiG , CosmiB , LegnaniC , TosettoA , BrusiC , IorioA , et al. D‐dimer testing to determine the duration of anticoagulation therapy. New England Journal of Medicine2006;355(17):1780‐9. ">Palareti 2006</a>). </p> </section> </section> <section id="CD001367-sec-0063"> <h3 class="title">Risk of bias in included studies</h3> <p>See also the <a href="#CD001367-sec-0063">Risk of bias in included studies</a> summary (<a href="#CD001367-fig-0002">Figure 2</a> and <a href="#CD001367-fig-0003">Figure 3</a>). </p> <div class="figure" id="CD001367-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD001367-fig-0002" src="/cdsr/doi/10.1002/14651858.CD001367.pub3/media/CDSR/CD001367/image_n/nCD001367-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <div class="figure" id="CD001367-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD001367-fig-0003" src="/cdsr/doi/10.1002/14651858.CD001367.pub3/media/CDSR/CD001367/image_n/nCD001367-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <section id="CD001367-sec-0064"> <h4 class="title">Allocation</h4> <p>Nine studies (82%) were deemed to have adequate sequence generation and therefore were classified as being at low risk of bias for this domain (<a href="./references#CD001367-bbs2-0001" title="AgnelliG , PrandoniP , SantamariaMG , BagatellaP , IorioA , BazzanM , et al. Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. New England Journal of Medicine2001;345(3):165‐9. ">Agnelli 2001</a>; <a href="./references#CD001367-bbs2-0002" title="AgnelliG , PrandoniP , BecattiniC , SilingardiM , TalianiMR , MiccioM , et al. Extended oral anticoagulant therapy after first episode of pulmonary embolism. Annals of Internal Medicine2003;139(1):19‐25. ">Agnelli 2003</a>; <a href="./references#CD001367-bbs2-0004" title="KearonC , GentM , HirshJ , WeitzJ , KovacsMJ , AndersonDR , et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. New England Journal of Medicine1999;340(12):901‐7. ">Kearon 1999</a>; <a href="./references#CD001367-bbs2-0005" title="KearonC , GinsbergJS , AndersonDR , KovacsMJ , WellsP , JulianJA , et al. Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor. Journal of Thrombosis and Haemostasis2004;2:743‐9. ">Kearon 2004</a>; <a href="./references#CD001367-bbs2-0006" title="LevineMN , HirshJ , GentM , TurpieAG , WeitzJ , GinsbergJ , et al. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis. Thrombosis and Haemostasis1995;74(2):606‐11. LevineMN , HirshJ , GentM , TurpieAG , WeitzJ , GinsburgJ , et al. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis (DVT). Thrombosis and Haemostasis1993; Vol. 69, issue 6:982. Abstract No 1581. ">Levine 1995</a>; <a href="./references#CD001367-bbs2-0007" title="PinedeL , NinetJ , DuhautP , ChabaudS , Demolombe‐RagueS , DurieuI , et al. Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis. Circulation2001;103(20):2453‐60. ">Pinede 2001</a>; <a href="./references#CD001367-bbs2-0009" title="SchulmanS , RhedinA‐S , LindmarkerP , CarlssonA , LarfarsG , NicolP , et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. New England Journal of Medicine1995;332(25):1661‐5. ">Schulman 1995</a>; <a href="./references#CD001367-bbs2-0010" title="SchulmanS , GranqvistS , HolmstromM , CarlssonA , LindmarkerP , NicolP , et al. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. New England Journal of Medicine1997;336(6):393‐8. ">Schulman 1997</a>; <a href="./references#CD001367-bbs2-0011" title="SiragusaS , MalatoA , AnastasioR , CignaV , MilioG , AmatoC , et al. Residual vein thrombosis to establish duration of anticoagulation after a first episode of deep vein thrombosis: the Duration of Anticoagulation based on Compression Ultrasound (DACUS) study. Blood2008;112(3):511‐5. ">Siragusa 2008</a>). The risk of bias was unclear for two studies because they did not provide information about the randomization process (<a href="./references#CD001367-bbs2-0003" title="EischerL , GartnerV , SchulmanS , KyrlePA , EichingerS . 6 versus 30 months anticoagulation for recurrent venous thrombosis in patients with high factor VIII. Annals of Hematology2009;88:485‐90. ">Eischer 2009</a>; <a href="./references#CD001367-bbs2-0008" title="RidkerP , GoldhaberS , GlynnR . Long‐term, low‐intensity warfarin for the prevention of recurrent venous thromboembolism: the PREVENT trial. Journal of Thrombosis and Haemostasis2003; Vol. 1, issue Suppl 1:Abstract OC001. RidkerPM , GoldhaberSZ , DanielsonE , RosenbergY , EbyCS , DeitcherSR , et al. Long‐term, low‐intensity warfarin therapy for the prevention of recurrent venous thromboembolism. New England Journal of Medicine2003;348(15):1425‐34. ">Ridker 2003</a>). In eight studies, the assigned treatment was adequately concealed before allocation (low risk of selection bias) (<a href="./references#CD001367-bbs2-0001" title="AgnelliG , PrandoniP , SantamariaMG , BagatellaP , IorioA , BazzanM , et al. Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. New England Journal of Medicine2001;345(3):165‐9. ">Agnelli 2001</a>; <a href="./references#CD001367-bbs2-0002" title="AgnelliG , PrandoniP , BecattiniC , SilingardiM , TalianiMR , MiccioM , et al. Extended oral anticoagulant therapy after first episode of pulmonary embolism. Annals of Internal Medicine2003;139(1):19‐25. ">Agnelli 2003</a>; <a href="./references#CD001367-bbs2-0004" title="KearonC , GentM , HirshJ , WeitzJ , KovacsMJ , AndersonDR , et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. New England Journal of Medicine1999;340(12):901‐7. ">Kearon 1999</a>; <a href="./references#CD001367-bbs2-0005" title="KearonC , GinsbergJS , AndersonDR , KovacsMJ , WellsP , JulianJA , et al. Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor. Journal of Thrombosis and Haemostasis2004;2:743‐9. ">Kearon 2004</a>; <a href="./references#CD001367-bbs2-0006" title="LevineMN , HirshJ , GentM , TurpieAG , WeitzJ , GinsbergJ , et al. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis. Thrombosis and Haemostasis1995;74(2):606‐11. LevineMN , HirshJ , GentM , TurpieAG , WeitzJ , GinsburgJ , et al. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis (DVT). Thrombosis and Haemostasis1993; Vol. 69, issue 6:982. Abstract No 1581. ">Levine 1995</a>; <a href="./references#CD001367-bbs2-0007" title="PinedeL , NinetJ , DuhautP , ChabaudS , Demolombe‐RagueS , DurieuI , et al. Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis. Circulation2001;103(20):2453‐60. ">Pinede 2001</a>; <a href="./references#CD001367-bbs2-0009" title="SchulmanS , RhedinA‐S , LindmarkerP , CarlssonA , LarfarsG , NicolP , et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. New England Journal of Medicine1995;332(25):1661‐5. ">Schulman 1995</a>; <a href="./references#CD001367-bbs2-0010" title="SchulmanS , GranqvistS , HolmstromM , CarlssonA , LindmarkerP , NicolP , et al. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. New England Journal of Medicine1997;336(6):393‐8. ">Schulman 1997</a>) and was unclear for the remaining three studies (<a href="./references#CD001367-bbs2-0003" title="EischerL , GartnerV , SchulmanS , KyrlePA , EichingerS . 6 versus 30 months anticoagulation for recurrent venous thrombosis in patients with high factor VIII. Annals of Hematology2009;88:485‐90. ">Eischer 2009</a>; <a href="./references#CD001367-bbs2-0008" title="RidkerP , GoldhaberS , GlynnR . Long‐term, low‐intensity warfarin for the prevention of recurrent venous thromboembolism: the PREVENT trial. Journal of Thrombosis and Haemostasis2003; Vol. 1, issue Suppl 1:Abstract OC001. RidkerPM , GoldhaberSZ , DanielsonE , RosenbergY , EbyCS , DeitcherSR , et al. Long‐term, low‐intensity warfarin therapy for the prevention of recurrent venous thromboembolism. New England Journal of Medicine2003;348(15):1425‐34. ">Ridker 2003</a>; <a href="./references#CD001367-bbs2-0011" title="SiragusaS , MalatoA , AnastasioR , CignaV , MilioG , AmatoC , et al. Residual vein thrombosis to establish duration of anticoagulation after a first episode of deep vein thrombosis: the Duration of Anticoagulation based on Compression Ultrasound (DACUS) study. Blood2008;112(3):511‐5. ">Siragusa 2008</a>). </p> </section> <section id="CD001367-sec-0065"> <h4 class="title">Blinding</h4> <p>In four of the included studies, participants were randomly assigned to the sham duration of treatment with VKA and received placebo and sham monitoring (<a href="./references#CD001367-bbs2-0004" title="KearonC , GentM , HirshJ , WeitzJ , KovacsMJ , AndersonDR , et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. New England Journal of Medicine1999;340(12):901‐7. ">Kearon 1999</a>; <a href="./references#CD001367-bbs2-0005" title="KearonC , GinsbergJS , AndersonDR , KovacsMJ , WellsP , JulianJA , et al. Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor. Journal of Thrombosis and Haemostasis2004;2:743‐9. ">Kearon 2004</a>; <a href="./references#CD001367-bbs2-0006" title="LevineMN , HirshJ , GentM , TurpieAG , WeitzJ , GinsbergJ , et al. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis. Thrombosis and Haemostasis1995;74(2):606‐11. LevineMN , HirshJ , GentM , TurpieAG , WeitzJ , GinsburgJ , et al. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis (DVT). Thrombosis and Haemostasis1993; Vol. 69, issue 6:982. Abstract No 1581. ">Levine 1995</a>; <a href="./references#CD001367-bbs2-0008" title="RidkerP , GoldhaberS , GlynnR . Long‐term, low‐intensity warfarin for the prevention of recurrent venous thromboembolism: the PREVENT trial. Journal of Thrombosis and Haemostasis2003; Vol. 1, issue Suppl 1:Abstract OC001. RidkerPM , GoldhaberSZ , DanielsonE , RosenbergY , EbyCS , DeitcherSR , et al. Long‐term, low‐intensity warfarin therapy for the prevention of recurrent venous thromboembolism. New England Journal of Medicine2003;348(15):1425‐34. ">Ridker 2003</a>). These studies were classified as being at low risk for performance bias. In the other seven included studies, treatment was not blinded (<a href="./references#CD001367-bbs2-0001" title="AgnelliG , PrandoniP , SantamariaMG , BagatellaP , IorioA , BazzanM , et al. Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. New England Journal of Medicine2001;345(3):165‐9. ">Agnelli 2001</a>; <a href="./references#CD001367-bbs2-0002" title="AgnelliG , PrandoniP , BecattiniC , SilingardiM , TalianiMR , MiccioM , et al. Extended oral anticoagulant therapy after first episode of pulmonary embolism. Annals of Internal Medicine2003;139(1):19‐25. ">Agnelli 2003</a>; <a href="./references#CD001367-bbs2-0003" title="EischerL , GartnerV , SchulmanS , KyrlePA , EichingerS . 6 versus 30 months anticoagulation for recurrent venous thrombosis in patients with high factor VIII. Annals of Hematology2009;88:485‐90. ">Eischer 2009</a>; <a href="./references#CD001367-bbs2-0007" title="PinedeL , NinetJ , DuhautP , ChabaudS , Demolombe‐RagueS , DurieuI , et al. Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis. Circulation2001;103(20):2453‐60. ">Pinede 2001</a>; <a href="./references#CD001367-bbs2-0009" title="SchulmanS , RhedinA‐S , LindmarkerP , CarlssonA , LarfarsG , NicolP , et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. New England Journal of Medicine1995;332(25):1661‐5. ">Schulman 1995</a>; <a href="./references#CD001367-bbs2-0010" title="SchulmanS , GranqvistS , HolmstromM , CarlssonA , LindmarkerP , NicolP , et al. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. New England Journal of Medicine1997;336(6):393‐8. ">Schulman 1997</a>; <a href="./references#CD001367-bbs2-0011" title="SiragusaS , MalatoA , AnastasioR , CignaV , MilioG , AmatoC , et al. Residual vein thrombosis to establish duration of anticoagulation after a first episode of deep vein thrombosis: the Duration of Anticoagulation based on Compression Ultrasound (DACUS) study. Blood2008;112(3):511‐5. ">Siragusa 2008</a>). Outcome assessment was performed by a committee unaware of treatment allocation in all studies. In two of these studies, blinded outcome assessment was performed only for recurrent VTE, not for bleeding events (<a href="./references#CD001367-bbs2-0009" title="SchulmanS , RhedinA‐S , LindmarkerP , CarlssonA , LarfarsG , NicolP , et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. New England Journal of Medicine1995;332(25):1661‐5. ">Schulman 1995</a>; <a href="./references#CD001367-bbs2-0010" title="SchulmanS , GranqvistS , HolmstromM , CarlssonA , LindmarkerP , NicolP , et al. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. New England Journal of Medicine1997;336(6):393‐8. ">Schulman 1997</a>). For these studies, the risk for detection bias was classified as unclear. </p> </section> <section id="CD001367-sec-0066"> <h4 class="title">Incomplete outcome data</h4> <p>One trial reported that 0.6% of participants were excluded after randomization (<a href="./references#CD001367-bbs2-0009" title="SchulmanS , RhedinA‐S , LindmarkerP , CarlssonA , LarfarsG , NicolP , et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. New England Journal of Medicine1995;332(25):1661‐5. ">Schulman 1995</a>), and another study reported that 2.7% of participants withdrew shortly after randomization (<a href="./references#CD001367-bbs2-0006" title="LevineMN , HirshJ , GentM , TurpieAG , WeitzJ , GinsbergJ , et al. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis. Thrombosis and Haemostasis1995;74(2):606‐11. LevineMN , HirshJ , GentM , TurpieAG , WeitzJ , GinsburgJ , et al. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis (DVT). Thrombosis and Haemostasis1993; Vol. 69, issue 6:982. Abstract No 1581. ">Levine 1995</a>). In two studies, 3% of participants were lost to follow‐up (<a href="./references#CD001367-bbs2-0006" title="LevineMN , HirshJ , GentM , TurpieAG , WeitzJ , GinsbergJ , et al. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis. Thrombosis and Haemostasis1995;74(2):606‐11. LevineMN , HirshJ , GentM , TurpieAG , WeitzJ , GinsburgJ , et al. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis (DVT). Thrombosis and Haemostasis1993; Vol. 69, issue 6:982. Abstract No 1581. ">Levine 1995</a>; <a href="./references#CD001367-bbs2-0007" title="PinedeL , NinetJ , DuhautP , ChabaudS , Demolombe‐RagueS , DurieuI , et al. Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis. Circulation2001;103(20):2453‐60. ">Pinede 2001</a>). <a href="./references#CD001367-bbs2-0009" title="SchulmanS , RhedinA‐S , LindmarkerP , CarlssonA , LarfarsG , NicolP , et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. New England Journal of Medicine1995;332(25):1661‐5. ">Schulman 1995</a> and <a href="./references#CD001367-bbs2-0010" title="SchulmanS , GranqvistS , HolmstromM , CarlssonA , LindmarkerP , NicolP , et al. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. New England Journal of Medicine1997;336(6):393‐8. ">Schulman 1997</a> mentioned that 4.9% and 6.2% of participants dropped out; however, the study authors were able to collect information about outcome events among these participants from computer registries. </p> </section> <section id="CD001367-sec-0067"> <h4 class="title">Selective reporting</h4> <p>Only one study was registered at clinicaltrial.gov (<a href="./references#CD001367-bbs2-0011" title="SiragusaS , MalatoA , AnastasioR , CignaV , MilioG , AmatoC , et al. Residual vein thrombosis to establish duration of anticoagulation after a first episode of deep vein thrombosis: the Duration of Anticoagulation based on Compression Ultrasound (DACUS) study. Blood2008;112(3):511‐5. ">Siragusa 2008</a>), and all prespecified outcomes of interest in the review were reported in the prespecified way in the final publication. Therefore the risk for reporting bias was considered low in this study. For the remaining studies, the risk of reporting bias was classified as unclear. </p> </section> <section id="CD001367-sec-0068"> <h4 class="title">Other potential sources of bias</h4> <p>Upon review of the studies, no other potential sources of bias were identified.</p> </section> </section> <section id="CD001367-sec-0069"> <h3 class="title" id="CD001367-sec-0069">Effects of interventions</h3> <p>See: <a href="./full#CD001367-tbl-0001"><b>Summary of findings for the main comparison</b> Long‐term or short‐term treatment with vitamin K antagonists for patients with venous thromboembolism</a> </p> <section id="CD001367-sec-0070"> <h4 class="title">Incidence of recurrent VTE</h4> <p>Ten of the 11 studies reported on the occurrence of symptomatic VTE during the period from cessation of treatment with VKA in the short duration arm until cessation of treatment in the long duration arm (<a href="./references#CD001367-bbs2-0001" title="AgnelliG , PrandoniP , SantamariaMG , BagatellaP , IorioA , BazzanM , et al. Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. New England Journal of Medicine2001;345(3):165‐9. ">Agnelli 2001</a>; <a href="./references#CD001367-bbs2-0002" title="AgnelliG , PrandoniP , BecattiniC , SilingardiM , TalianiMR , MiccioM , et al. Extended oral anticoagulant therapy after first episode of pulmonary embolism. Annals of Internal Medicine2003;139(1):19‐25. ">Agnelli 2003</a>; <a href="./references#CD001367-bbs2-0003" title="EischerL , GartnerV , SchulmanS , KyrlePA , EichingerS . 6 versus 30 months anticoagulation for recurrent venous thrombosis in patients with high factor VIII. Annals of Hematology2009;88:485‐90. ">Eischer 2009</a>; <a href="./references#CD001367-bbs2-0004" title="KearonC , GentM , HirshJ , WeitzJ , KovacsMJ , AndersonDR , et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. New England Journal of Medicine1999;340(12):901‐7. ">Kearon 1999</a>; <a href="./references#CD001367-bbs2-0005" title="KearonC , GinsbergJS , AndersonDR , KovacsMJ , WellsP , JulianJA , et al. Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor. Journal of Thrombosis and Haemostasis2004;2:743‐9. ">Kearon 2004</a>; <a href="./references#CD001367-bbs2-0006" title="LevineMN , HirshJ , GentM , TurpieAG , WeitzJ , GinsbergJ , et al. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis. Thrombosis and Haemostasis1995;74(2):606‐11. LevineMN , HirshJ , GentM , TurpieAG , WeitzJ , GinsburgJ , et al. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis (DVT). Thrombosis and Haemostasis1993; Vol. 69, issue 6:982. Abstract No 1581. ">Levine 1995</a>; <a href="./references#CD001367-bbs2-0007" title="PinedeL , NinetJ , DuhautP , ChabaudS , Demolombe‐RagueS , DurieuI , et al. Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis. Circulation2001;103(20):2453‐60. ">Pinede 2001</a>; <a href="./references#CD001367-bbs2-0008" title="RidkerP , GoldhaberS , GlynnR . Long‐term, low‐intensity warfarin for the prevention of recurrent venous thromboembolism: the PREVENT trial. Journal of Thrombosis and Haemostasis2003; Vol. 1, issue Suppl 1:Abstract OC001. RidkerPM , GoldhaberSZ , DanielsonE , RosenbergY , EbyCS , DeitcherSR , et al. Long‐term, low‐intensity warfarin therapy for the prevention of recurrent venous thromboembolism. New England Journal of Medicine2003;348(15):1425‐34. ">Ridker 2003</a>; <a href="./references#CD001367-bbs2-0009" title="SchulmanS , RhedinA‐S , LindmarkerP , CarlssonA , LarfarsG , NicolP , et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. New England Journal of Medicine1995;332(25):1661‐5. ">Schulman 1995</a>; <a href="./references#CD001367-bbs2-0010" title="SchulmanS , GranqvistS , HolmstromM , CarlssonA , LindmarkerP , NicolP , et al. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. New England Journal of Medicine1997;336(6):393‐8. ">Schulman 1997</a>). </p> <p>Five of the 10 studies showed statistically significant protection from recurrent venous thromboembolic complications during prolonged treatment with VKA (<a href="./references#CD001367-bbs2-0004" title="KearonC , GentM , HirshJ , WeitzJ , KovacsMJ , AndersonDR , et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. New England Journal of Medicine1999;340(12):901‐7. ">Kearon 1999</a>; <a href="./references#CD001367-bbs2-0006" title="LevineMN , HirshJ , GentM , TurpieAG , WeitzJ , GinsbergJ , et al. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis. Thrombosis and Haemostasis1995;74(2):606‐11. LevineMN , HirshJ , GentM , TurpieAG , WeitzJ , GinsburgJ , et al. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis (DVT). Thrombosis and Haemostasis1993; Vol. 69, issue 6:982. Abstract No 1581. ">Levine 1995</a>; <a href="./references#CD001367-bbs2-0008" title="RidkerP , GoldhaberS , GlynnR . Long‐term, low‐intensity warfarin for the prevention of recurrent venous thromboembolism: the PREVENT trial. Journal of Thrombosis and Haemostasis2003; Vol. 1, issue Suppl 1:Abstract OC001. RidkerPM , GoldhaberSZ , DanielsonE , RosenbergY , EbyCS , DeitcherSR , et al. Long‐term, low‐intensity warfarin therapy for the prevention of recurrent venous thromboembolism. New England Journal of Medicine2003;348(15):1425‐34. ">Ridker 2003</a>; <a href="./references#CD001367-bbs2-0009" title="SchulmanS , RhedinA‐S , LindmarkerP , CarlssonA , LarfarsG , NicolP , et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. New England Journal of Medicine1995;332(25):1661‐5. ">Schulman 1995</a>; <a href="./references#CD001367-bbs2-0010" title="SchulmanS , GranqvistS , HolmstromM , CarlssonA , LindmarkerP , NicolP , et al. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. New England Journal of Medicine1997;336(6):393‐8. ">Schulman 1997</a>). Four studies showed a clear trend (<a href="./references#CD001367-bbs2-0001" title="AgnelliG , PrandoniP , SantamariaMG , BagatellaP , IorioA , BazzanM , et al. Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. New England Journal of Medicine2001;345(3):165‐9. ">Agnelli 2001</a>; <a href="./references#CD001367-bbs2-0002" title="AgnelliG , PrandoniP , BecattiniC , SilingardiM , TalianiMR , MiccioM , et al. Extended oral anticoagulant therapy after first episode of pulmonary embolism. Annals of Internal Medicine2003;139(1):19‐25. ">Agnelli 2003</a>; <a href="./references#CD001367-bbs2-0005" title="KearonC , GinsbergJS , AndersonDR , KovacsMJ , WellsP , JulianJA , et al. Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor. Journal of Thrombosis and Haemostasis2004;2:743‐9. ">Kearon 2004</a>; <a href="./references#CD001367-bbs2-0007" title="PinedeL , NinetJ , DuhautP , ChabaudS , Demolombe‐RagueS , DurieuI , et al. Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis. Circulation2001;103(20):2453‐60. ">Pinede 2001</a>). The study of <a href="./references#CD001367-bbs2-0003" title="EischerL , GartnerV , SchulmanS , KyrlePA , EichingerS . 6 versus 30 months anticoagulation for recurrent venous thrombosis in patients with high factor VIII. Annals of Hematology2009;88:485‐90. ">Eischer 2009</a> showed no difference (<a href="./references#CD001367-fig-0004" title="">Analysis 1.1</a>). Combining the ten studies revealed that 155 (8.8%) of 1765 participants had thromboembolic complications in the short arm, and only 30 (1.6%) of 1771 participants had thromboembolic complications in the long arm. Analysis of pooled data from these studies showed a statistically significant reduction in thromboembolic events during this period (RR 0.20, 95% CI 0.11 to 0.38, P &lt; 0.00001). </p> <p>Seven of the 11 studies evaluated the incidence of recurrent VTE in the period after cessation of study medication until the end of follow‐up (<a href="./references#CD001367-bbs2-0001" title="AgnelliG , PrandoniP , SantamariaMG , BagatellaP , IorioA , BazzanM , et al. Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. New England Journal of Medicine2001;345(3):165‐9. ">Agnelli 2001</a>; <a href="./references#CD001367-bbs2-0002" title="AgnelliG , PrandoniP , BecattiniC , SilingardiM , TalianiMR , MiccioM , et al. Extended oral anticoagulant therapy after first episode of pulmonary embolism. Annals of Internal Medicine2003;139(1):19‐25. ">Agnelli 2003</a>; <a href="./references#CD001367-bbs2-0003" title="EischerL , GartnerV , SchulmanS , KyrlePA , EichingerS . 6 versus 30 months anticoagulation for recurrent venous thrombosis in patients with high factor VIII. Annals of Hematology2009;88:485‐90. ">Eischer 2009</a>; <a href="./references#CD001367-bbs2-0005" title="KearonC , GinsbergJS , AndersonDR , KovacsMJ , WellsP , JulianJA , et al. Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor. Journal of Thrombosis and Haemostasis2004;2:743‐9. ">Kearon 2004</a>; <a href="./references#CD001367-bbs2-0006" title="LevineMN , HirshJ , GentM , TurpieAG , WeitzJ , GinsbergJ , et al. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis. Thrombosis and Haemostasis1995;74(2):606‐11. LevineMN , HirshJ , GentM , TurpieAG , WeitzJ , GinsburgJ , et al. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis (DVT). Thrombosis and Haemostasis1993; Vol. 69, issue 6:982. Abstract No 1581. ">Levine 1995</a>; <a href="./references#CD001367-bbs2-0007" title="PinedeL , NinetJ , DuhautP , ChabaudS , Demolombe‐RagueS , DurieuI , et al. Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis. Circulation2001;103(20):2453‐60. ">Pinede 2001</a>; <a href="./references#CD001367-bbs2-0009" title="SchulmanS , RhedinA‐S , LindmarkerP , CarlssonA , LarfarsG , NicolP , et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. New England Journal of Medicine1995;332(25):1661‐5. ">Schulman 1995</a>). These individual studies did not show a statistically significant increase in venous thromboembolic events among participants in the long arm after cessation of treatment. Combining these studies showed that 101 (7.6%) of 1321 participants who were treated for the longer period with VKA and 78 (5.9%) of 1318 participants who were treated for a shorter period experienced a recurrence (<a href="./references#CD001367-fig-0007" title="">Analysis 2.1</a>). Analysis of the pooled data showed a non–statistically significant difference in the incidence of recurrence during this period (RR 1.28, 95% CI 0.97 to 1.70, P = 0.09). Although a somewhat higher risk was found for participants in the long duration arm after cessation of treatment compared with those in the short duration arm, a rebound effect could not be clearly demonstrated. </p> <p>When the entire period after randomization reported in the publication was considered, four of the 11 studies showed statistically significant protection from recurrent thromboembolic complications (<a href="./references#CD001367-bbs2-0004" title="KearonC , GentM , HirshJ , WeitzJ , KovacsMJ , AndersonDR , et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. New England Journal of Medicine1999;340(12):901‐7. ">Kearon 1999</a>; <a href="./references#CD001367-bbs2-0008" title="RidkerP , GoldhaberS , GlynnR . Long‐term, low‐intensity warfarin for the prevention of recurrent venous thromboembolism: the PREVENT trial. Journal of Thrombosis and Haemostasis2003; Vol. 1, issue Suppl 1:Abstract OC001. RidkerPM , GoldhaberSZ , DanielsonE , RosenbergY , EbyCS , DeitcherSR , et al. Long‐term, low‐intensity warfarin therapy for the prevention of recurrent venous thromboembolism. New England Journal of Medicine2003;348(15):1425‐34. ">Ridker 2003</a>; <a href="./references#CD001367-bbs2-0009" title="SchulmanS , RhedinA‐S , LindmarkerP , CarlssonA , LarfarsG , NicolP , et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. New England Journal of Medicine1995;332(25):1661‐5. ">Schulman 1995</a>; <a href="./references#CD001367-bbs2-0010" title="SchulmanS , GranqvistS , HolmstromM , CarlssonA , LindmarkerP , NicolP , et al. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. New England Journal of Medicine1997;336(6):393‐8. ">Schulman 1997</a>). See <a href="./references#CD001367-fig-0010" title="">Analysis 3.1</a>. Substantial heterogeneity could be observed between the studies (P = 0.0005, I<sup>2</sup> = 68%). Graphically, two groups can be identified: those with extended follow‐up after cessation of treatment with VKA in the long arm (<a href="./references#CD001367-bbs2-0001" title="AgnelliG , PrandoniP , SantamariaMG , BagatellaP , IorioA , BazzanM , et al. Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. New England Journal of Medicine2001;345(3):165‐9. ">Agnelli 2001</a>; <a href="./references#CD001367-bbs2-0002" title="AgnelliG , PrandoniP , BecattiniC , SilingardiM , TalianiMR , MiccioM , et al. Extended oral anticoagulant therapy after first episode of pulmonary embolism. Annals of Internal Medicine2003;139(1):19‐25. ">Agnelli 2003</a>; <a href="./references#CD001367-bbs2-0003" title="EischerL , GartnerV , SchulmanS , KyrlePA , EichingerS . 6 versus 30 months anticoagulation for recurrent venous thrombosis in patients with high factor VIII. Annals of Hematology2009;88:485‐90. ">Eischer 2009</a>; <a href="./references#CD001367-bbs2-0005" title="KearonC , GinsbergJS , AndersonDR , KovacsMJ , WellsP , JulianJA , et al. Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor. Journal of Thrombosis and Haemostasis2004;2:743‐9. ">Kearon 2004</a>; <a href="./references#CD001367-bbs2-0006" title="LevineMN , HirshJ , GentM , TurpieAG , WeitzJ , GinsbergJ , et al. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis. Thrombosis and Haemostasis1995;74(2):606‐11. LevineMN , HirshJ , GentM , TurpieAG , WeitzJ , GinsburgJ , et al. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis (DVT). Thrombosis and Haemostasis1993; Vol. 69, issue 6:982. Abstract No 1581. ">Levine 1995</a>; <a href="./references#CD001367-bbs2-0007" title="PinedeL , NinetJ , DuhautP , ChabaudS , Demolombe‐RagueS , DurieuI , et al. Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis. Circulation2001;103(20):2453‐60. ">Pinede 2001</a>; <a href="./references#CD001367-bbs2-0008" title="RidkerP , GoldhaberS , GlynnR . Long‐term, low‐intensity warfarin for the prevention of recurrent venous thromboembolism: the PREVENT trial. Journal of Thrombosis and Haemostasis2003; Vol. 1, issue Suppl 1:Abstract OC001. RidkerPM , GoldhaberSZ , DanielsonE , RosenbergY , EbyCS , DeitcherSR , et al. Long‐term, low‐intensity warfarin therapy for the prevention of recurrent venous thromboembolism. New England Journal of Medicine2003;348(15):1425‐34. ">Ridker 2003</a>; <a href="./references#CD001367-bbs2-0009" title="SchulmanS , RhedinA‐S , LindmarkerP , CarlssonA , LarfarsG , NicolP , et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. New England Journal of Medicine1995;332(25):1661‐5. ">Schulman 1995</a>; <a href="./references#CD001367-bbs2-0011" title="SiragusaS , MalatoA , AnastasioR , CignaV , MilioG , AmatoC , et al. Residual vein thrombosis to establish duration of anticoagulation after a first episode of deep vein thrombosis: the Duration of Anticoagulation based on Compression Ultrasound (DACUS) study. Blood2008;112(3):511‐5. ">Siragusa 2008</a>) (pooled data: RR 0.74, 95% CI 0.54 to 1.01) and those without extended follow‐up after cessation of treatment with VKA in the long arm (<a href="./references#CD001367-bbs2-0004" title="KearonC , GentM , HirshJ , WeitzJ , KovacsMJ , AndersonDR , et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. New England Journal of Medicine1999;340(12):901‐7. ">Kearon 1999</a>; <a href="./references#CD001367-bbs2-0010" title="SchulmanS , GranqvistS , HolmstromM , CarlssonA , LindmarkerP , NicolP , et al. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. New England Journal of Medicine1997;336(6):393‐8. ">Schulman 1997</a>) (pooled data: RR 0.10, 95% CI 0.04 to 0.29). Therefore, we decided to refrain from pooling all studies. </p> <section id="CD001367-sec-0071"> <h5 class="title">Comparisons of two specific durations</h5> <p>It was possible to extract data from more than one study for the following durations.</p> <section id="CD001367-sec-0072"> <h6 class="title">One month versus three months</h6> <p>Pooling the data from <a href="./references#CD001367-bbs2-0005" title="KearonC , GinsbergJS , AndersonDR , KovacsMJ , WellsP , JulianJA , et al. Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor. Journal of Thrombosis and Haemostasis2004;2:743‐9. ">Kearon 2004</a> and <a href="./references#CD001367-bbs2-0006" title="LevineMN , HirshJ , GentM , TurpieAG , WeitzJ , GinsbergJ , et al. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis. Thrombosis and Haemostasis1995;74(2):606‐11. LevineMN , HirshJ , GentM , TurpieAG , WeitzJ , GinsburgJ , et al. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis (DVT). Thrombosis and Haemostasis1993; Vol. 69, issue 6:982. Abstract No 1581. ">Levine 1995</a> showed a significant reduction in recurrent VTE in participants who had received prolonged VKA treatment (RR 0.18, 95% CI 0.04 to 0.79, P = 0.02). See <a href="./references#CD001367-fig-0013" title="">Analysis 4.1</a>. </p> </section> <section id="CD001367-sec-0073"> <h6 class="title">Three months versus six months</h6> <p>Pooling the data from <a href="./references#CD001367-bbs2-0001" title="AgnelliG , PrandoniP , SantamariaMG , BagatellaP , IorioA , BazzanM , et al. Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. New England Journal of Medicine2001;345(3):165‐9. ">Agnelli 2001</a>, <a href="./references#CD001367-bbs2-0002" title="AgnelliG , PrandoniP , BecattiniC , SilingardiM , TalianiMR , MiccioM , et al. Extended oral anticoagulant therapy after first episode of pulmonary embolism. Annals of Internal Medicine2003;139(1):19‐25. ">Agnelli 2003</a>, <a href="./references#CD001367-bbs2-0004" title="KearonC , GentM , HirshJ , WeitzJ , KovacsMJ , AndersonDR , et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. New England Journal of Medicine1999;340(12):901‐7. ">Kearon 1999</a>, and <a href="./references#CD001367-bbs2-0007" title="PinedeL , NinetJ , DuhautP , ChabaudS , Demolombe‐RagueS , DurieuI , et al. Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis. Circulation2001;103(20):2453‐60. ">Pinede 2001</a> showed a significant reduction in recurrent VTE among participants who had received prolonged VKA treatment (RR 0.10, 95% CI 0.02 to 0.43, P = 0.002). See <a href="./references#CD001367-fig-0014" title="">Analysis 5.1</a>. </p> </section> <section id="CD001367-sec-0074"> <h6 class="title">Three months versus 12 months</h6> <p>Pooling the data from <a href="./references#CD001367-bbs2-0001" title="AgnelliG , PrandoniP , SantamariaMG , BagatellaP , IorioA , BazzanM , et al. Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. New England Journal of Medicine2001;345(3):165‐9. ">Agnelli 2001</a>, <a href="./references#CD001367-bbs2-0002" title="AgnelliG , PrandoniP , BecattiniC , SilingardiM , TalianiMR , MiccioM , et al. Extended oral anticoagulant therapy after first episode of pulmonary embolism. Annals of Internal Medicine2003;139(1):19‐25. ">Agnelli 2003</a>, and <a href="./references#CD001367-bbs2-0004" title="KearonC , GentM , HirshJ , WeitzJ , KovacsMJ , AndersonDR , et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. New England Journal of Medicine1999;340(12):901‐7. ">Kearon 1999</a> revealed a significant reduction in recurrent VTE among participants who had received prolonged VKA treatment (RR 0.18, 95% CI 0.071 to 0.45, P = 0.0002). See <a href="./references#CD001367-fig-0015" title="">Analysis 6.1</a>. </p> </section> </section> </section> <section id="CD001367-sec-0075"> <h4 class="title">Incidence of major bleeding</h4> <p>Six studies reported on the incidence of major bleeding during the period from cessation of treatment with VKA in the short duration arm until cessation of treatment in the long duration arm (<a href="./references#CD001367-bbs2-0001" title="AgnelliG , PrandoniP , SantamariaMG , BagatellaP , IorioA , BazzanM , et al. Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. New England Journal of Medicine2001;345(3):165‐9. ">Agnelli 2001</a>; <a href="./references#CD001367-bbs2-0003" title="EischerL , GartnerV , SchulmanS , KyrlePA , EichingerS . 6 versus 30 months anticoagulation for recurrent venous thrombosis in patients with high factor VIII. Annals of Hematology2009;88:485‐90. ">Eischer 2009</a>; <a href="./references#CD001367-bbs2-0004" title="KearonC , GentM , HirshJ , WeitzJ , KovacsMJ , AndersonDR , et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. New England Journal of Medicine1999;340(12):901‐7. ">Kearon 1999</a>; <a href="./references#CD001367-bbs2-0005" title="KearonC , GinsbergJS , AndersonDR , KovacsMJ , WellsP , JulianJA , et al. Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor. Journal of Thrombosis and Haemostasis2004;2:743‐9. ">Kearon 2004</a>; <a href="./references#CD001367-bbs2-0006" title="LevineMN , HirshJ , GentM , TurpieAG , WeitzJ , GinsbergJ , et al. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis. Thrombosis and Haemostasis1995;74(2):606‐11. LevineMN , HirshJ , GentM , TurpieAG , WeitzJ , GinsburgJ , et al. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis (DVT). Thrombosis and Haemostasis1993; Vol. 69, issue 6:982. Abstract No 1581. ">Levine 1995</a>; <a href="./references#CD001367-bbs2-0008" title="RidkerP , GoldhaberS , GlynnR . Long‐term, low‐intensity warfarin for the prevention of recurrent venous thromboembolism: the PREVENT trial. Journal of Thrombosis and Haemostasis2003; Vol. 1, issue Suppl 1:Abstract OC001. RidkerPM , GoldhaberSZ , DanielsonE , RosenbergY , EbyCS , DeitcherSR , et al. Long‐term, low‐intensity warfarin therapy for the prevention of recurrent venous thromboembolism. New England Journal of Medicine2003;348(15):1425‐34. ">Ridker 2003</a>). None of the individual studies showed a statistically significant increase in bleeding complications during prolonged treatment with VKA. Combining these studies revealed that three (0.4%) of 675 participants had major bleeding in the short treatment arm versus 14 (2.1%) of 675 participants in the long treatment arm (<a href="./references#CD001367-fig-0005" title="">Analysis 1.2</a>). Analysis of pooled data from these studies showed a statistically significant increase in major bleeding complications during this period (RR 3.44, 95% CI 1.22 to 9.74, P = 0.02). </p> <p>Two studies reported on the incidence of major bleeding in the period after cessation of study medication in the long duration arm until end of follow‐up (<a href="./references#CD001367-bbs2-0003" title="EischerL , GartnerV , SchulmanS , KyrlePA , EichingerS . 6 versus 30 months anticoagulation for recurrent venous thrombosis in patients with high factor VIII. Annals of Hematology2009;88:485‐90. ">Eischer 2009</a>; <a href="./references#CD001367-bbs2-0005" title="KearonC , GinsbergJS , AndersonDR , KovacsMJ , WellsP , JulianJA , et al. Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor. Journal of Thrombosis and Haemostasis2004;2:743‐9. ">Kearon 2004</a>). However, both studies reported no major bleeding events during this period. </p> <p>All included trials reported on the occurrence of major bleeding complications for the entire period after randomization until end of follow‐up (<a href="./references#CD001367-bbs2-0001" title="AgnelliG , PrandoniP , SantamariaMG , BagatellaP , IorioA , BazzanM , et al. Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. New England Journal of Medicine2001;345(3):165‐9. ">Agnelli 2001</a>; <a href="./references#CD001367-bbs2-0002" title="AgnelliG , PrandoniP , BecattiniC , SilingardiM , TalianiMR , MiccioM , et al. Extended oral anticoagulant therapy after first episode of pulmonary embolism. Annals of Internal Medicine2003;139(1):19‐25. ">Agnelli 2003</a>; <a href="./references#CD001367-bbs2-0003" title="EischerL , GartnerV , SchulmanS , KyrlePA , EichingerS . 6 versus 30 months anticoagulation for recurrent venous thrombosis in patients with high factor VIII. Annals of Hematology2009;88:485‐90. ">Eischer 2009</a>; <a href="./references#CD001367-bbs2-0004" title="KearonC , GentM , HirshJ , WeitzJ , KovacsMJ , AndersonDR , et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. New England Journal of Medicine1999;340(12):901‐7. ">Kearon 1999</a>; <a href="./references#CD001367-bbs2-0005" title="KearonC , GinsbergJS , AndersonDR , KovacsMJ , WellsP , JulianJA , et al. Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor. Journal of Thrombosis and Haemostasis2004;2:743‐9. ">Kearon 2004</a>; <a href="./references#CD001367-bbs2-0006" title="LevineMN , HirshJ , GentM , TurpieAG , WeitzJ , GinsbergJ , et al. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis. Thrombosis and Haemostasis1995;74(2):606‐11. LevineMN , HirshJ , GentM , TurpieAG , WeitzJ , GinsburgJ , et al. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis (DVT). Thrombosis and Haemostasis1993; Vol. 69, issue 6:982. Abstract No 1581. ">Levine 1995</a>; <a href="./references#CD001367-bbs2-0007" title="PinedeL , NinetJ , DuhautP , ChabaudS , Demolombe‐RagueS , DurieuI , et al. Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis. Circulation2001;103(20):2453‐60. ">Pinede 2001</a>; <a href="./references#CD001367-bbs2-0008" title="RidkerP , GoldhaberS , GlynnR . Long‐term, low‐intensity warfarin for the prevention of recurrent venous thromboembolism: the PREVENT trial. Journal of Thrombosis and Haemostasis2003; Vol. 1, issue Suppl 1:Abstract OC001. RidkerPM , GoldhaberSZ , DanielsonE , RosenbergY , EbyCS , DeitcherSR , et al. Long‐term, low‐intensity warfarin therapy for the prevention of recurrent venous thromboembolism. New England Journal of Medicine2003;348(15):1425‐34. ">Ridker 2003</a>; <a href="./references#CD001367-bbs2-0009" title="SchulmanS , RhedinA‐S , LindmarkerP , CarlssonA , LarfarsG , NicolP , et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. New England Journal of Medicine1995;332(25):1661‐5. ">Schulman 1995</a>; <a href="./references#CD001367-bbs2-0010" title="SchulmanS , GranqvistS , HolmstromM , CarlssonA , LindmarkerP , NicolP , et al. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. New England Journal of Medicine1997;336(6):393‐8. ">Schulman 1997</a>; <a href="./references#CD001367-bbs2-0011" title="SiragusaS , MalatoA , AnastasioR , CignaV , MilioG , AmatoC , et al. Residual vein thrombosis to establish duration of anticoagulation after a first episode of deep vein thrombosis: the Duration of Anticoagulation based on Compression Ultrasound (DACUS) study. Blood2008;112(3):511‐5. ">Siragusa 2008</a>). None of the individual studies showed a statistically significant increase in bleeding complications during prolonged treatment with VKA. Combining these studies revealed that 44 (2.4%) of 1859 participants with prolonged treatment and 16 (0.9%) of 1857 participants with short treatment had major bleeding (<a href="./references#CD001367-fig-0011" title="">Analysis 3.2</a>). Analysis of pooled data showed an increase in major bleeding during the entire study period (RR 2.609, 95% CI 1.51 to 4.49, P = 0.0006). </p> </section> <section id="CD001367-sec-0076"> <h4 class="title">Mortality</h4> <p>Four studies reported mortality during the period from cessation of treatment with VKA in the short duration arm until cessation of treatment in the long duration arm (<a href="./references#CD001367-bbs2-0004" title="KearonC , GentM , HirshJ , WeitzJ , KovacsMJ , AndersonDR , et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. New England Journal of Medicine1999;340(12):901‐7. ">Kearon 1999</a>; <a href="./references#CD001367-bbs2-0005" title="KearonC , GinsbergJS , AndersonDR , KovacsMJ , WellsP , JulianJA , et al. Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor. Journal of Thrombosis and Haemostasis2004;2:743‐9. ">Kearon 2004</a>; <a href="./references#CD001367-bbs2-0006" title="LevineMN , HirshJ , GentM , TurpieAG , WeitzJ , GinsbergJ , et al. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis. Thrombosis and Haemostasis1995;74(2):606‐11. LevineMN , HirshJ , GentM , TurpieAG , WeitzJ , GinsburgJ , et al. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis (DVT). Thrombosis and Haemostasis1993; Vol. 69, issue 6:982. Abstract No 1581. ">Levine 1995</a>; <a href="./references#CD001367-bbs2-0008" title="RidkerP , GoldhaberS , GlynnR . Long‐term, low‐intensity warfarin for the prevention of recurrent venous thromboembolism: the PREVENT trial. Journal of Thrombosis and Haemostasis2003; Vol. 1, issue Suppl 1:Abstract OC001. RidkerPM , GoldhaberSZ , DanielsonE , RosenbergY , EbyCS , DeitcherSR , et al. Long‐term, low‐intensity warfarin therapy for the prevention of recurrent venous thromboembolism. New England Journal of Medicine2003;348(15):1425‐34. ">Ridker 2003</a>). Two of these studies showed a non–statistically significant reduction in mortality during prolonged treatment with vitamin K antagonists (<a href="./references#CD001367-bbs2-0004" title="KearonC , GentM , HirshJ , WeitzJ , KovacsMJ , AndersonDR , et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. New England Journal of Medicine1999;340(12):901‐7. ">Kearon 1999</a>; <a href="./references#CD001367-bbs2-0008" title="RidkerP , GoldhaberS , GlynnR . Long‐term, low‐intensity warfarin for the prevention of recurrent venous thromboembolism: the PREVENT trial. Journal of Thrombosis and Haemostasis2003; Vol. 1, issue Suppl 1:Abstract OC001. RidkerPM , GoldhaberSZ , DanielsonE , RosenbergY , EbyCS , DeitcherSR , et al. Long‐term, low‐intensity warfarin therapy for the prevention of recurrent venous thromboembolism. New England Journal of Medicine2003;348(15):1425‐34. ">Ridker 2003</a>). No trend was observed in <a href="./references#CD001367-bbs2-0006" title="LevineMN , HirshJ , GentM , TurpieAG , WeitzJ , GinsbergJ , et al. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis. Thrombosis and Haemostasis1995;74(2):606‐11. LevineMN , HirshJ , GentM , TurpieAG , WeitzJ , GinsburgJ , et al. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis (DVT). Thrombosis and Haemostasis1993; Vol. 69, issue 6:982. Abstract No 1581. ">Levine 1995</a>. Combining these studies showed that 20 (3.8%) of 525 participants in the short arm died, as did 14 (2.7%) of 524 participants in the long arm (<a href="./references#CD001367-fig-0006" title="">Analysis 1.3</a>). Analysis of pooled data from these studies showed that prolonged treatment was associated with a non–statistically significant reduction in mortality (RR 0.69, 95% CI 0.35 to 1.34, P = 0.27). </p> <p>Only one study reported specifically on the number of participants who died during the period after cessation of study medication in the long arm until end of follow‐up (<a href="./references#CD001367-bbs2-0005" title="KearonC , GinsbergJS , AndersonDR , KovacsMJ , WellsP , JulianJA , et al. Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor. Journal of Thrombosis and Haemostasis2004;2:743‐9. ">Kearon 2004</a>). Nine studies reported on mortality for the entire period after randomization (<a href="./references#CD001367-bbs2-0001" title="AgnelliG , PrandoniP , SantamariaMG , BagatellaP , IorioA , BazzanM , et al. Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. New England Journal of Medicine2001;345(3):165‐9. ">Agnelli 2001</a>; <a href="./references#CD001367-bbs2-0002" title="AgnelliG , PrandoniP , BecattiniC , SilingardiM , TalianiMR , MiccioM , et al. Extended oral anticoagulant therapy after first episode of pulmonary embolism. Annals of Internal Medicine2003;139(1):19‐25. ">Agnelli 2003</a>; <a href="./references#CD001367-bbs2-0004" title="KearonC , GentM , HirshJ , WeitzJ , KovacsMJ , AndersonDR , et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. New England Journal of Medicine1999;340(12):901‐7. ">Kearon 1999</a>; <a href="./references#CD001367-bbs2-0005" title="KearonC , GinsbergJS , AndersonDR , KovacsMJ , WellsP , JulianJA , et al. Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor. Journal of Thrombosis and Haemostasis2004;2:743‐9. ">Kearon 2004</a>; <a href="./references#CD001367-bbs2-0006" title="LevineMN , HirshJ , GentM , TurpieAG , WeitzJ , GinsbergJ , et al. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis. Thrombosis and Haemostasis1995;74(2):606‐11. LevineMN , HirshJ , GentM , TurpieAG , WeitzJ , GinsburgJ , et al. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis (DVT). Thrombosis and Haemostasis1993; Vol. 69, issue 6:982. Abstract No 1581. ">Levine 1995</a>; <a href="./references#CD001367-bbs2-0007" title="PinedeL , NinetJ , DuhautP , ChabaudS , Demolombe‐RagueS , DurieuI , et al. Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis. Circulation2001;103(20):2453‐60. ">Pinede 2001</a>; <a href="./references#CD001367-bbs2-0008" title="RidkerP , GoldhaberS , GlynnR . Long‐term, low‐intensity warfarin for the prevention of recurrent venous thromboembolism: the PREVENT trial. Journal of Thrombosis and Haemostasis2003; Vol. 1, issue Suppl 1:Abstract OC001. RidkerPM , GoldhaberSZ , DanielsonE , RosenbergY , EbyCS , DeitcherSR , et al. Long‐term, low‐intensity warfarin therapy for the prevention of recurrent venous thromboembolism. New England Journal of Medicine2003;348(15):1425‐34. ">Ridker 2003</a>; <a href="./references#CD001367-bbs2-0009" title="SchulmanS , RhedinA‐S , LindmarkerP , CarlssonA , LarfarsG , NicolP , et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. New England Journal of Medicine1995;332(25):1661‐5. ">Schulman 1995</a>; <a href="./references#CD001367-bbs2-0010" title="SchulmanS , GranqvistS , HolmstromM , CarlssonA , LindmarkerP , NicolP , et al. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. New England Journal of Medicine1997;336(6):393‐8. ">Schulman 1997</a>). None showed a statistically significant reduction in mortality. Combining these studies revealed that 75 (4.3%) of 1753 participants died with prolonged treatment and 83 (4.7%) of 1749 participants died without prolonged treatment with VKA (<a href="./references#CD001367-fig-0012" title="">Analysis 3.3</a>). Analysis of pooled data showed a non–statistically significant reduction in mortality during the entire study period (RR 0.89, 95% CI 0.66 to 1.21, P = 0.46). </p> </section> <section id="CD001367-sec-0077"> <h4 class="title">Sensitivity analysis</h4> <section id="CD001367-sec-0078"> <h5 class="title">Analysis of studies with adequate concealment of allocation before randomization</h5> <p>Separate analyses for studies with adequate allocation concealment did not change the results significantly. </p> </section> <section id="CD001367-sec-0079"> <h5 class="title">Analysis of studies without missing values</h5> <p>Separate analyses for studies in which none of the participants dropped out or were lost to follow‐up did not change the results significantly. </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD001367-sec-0080" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD001367-sec-0080"></div> <section id="CD001367-sec-0081"> <h3 class="title" id="CD001367-sec-0081">Summary of main results</h3> <p>In this review, data from included studies were pooled to evaluate the efficacy and safety of different durations of treatment with VKA among participants with symptomatic VTE. </p> <p>We found a statistically significant reduction in recurrent VTE during the period in which treatment with VKA was prolonged, which was independent of the period elapsed since the index thromboembolic event (RR 0.20, 95% CI 0.11 to 0.38, P &lt; 0.00001). Although the periods of treatment differed greatly between studies, these periods could be combined because the relative effect of oral anticoagulant treatment was considered and was homogeneous during the period of continuation. Reduction in recurrent VTE during the period that treatment with VKA was prolonged may be somewhat counterbalanced by an excess of recurrences shortly after cessation of prolonged treatment, but this finding did not reach statistical significance (RR 1.28, 95% CI 0.97 to 1.70, P = 0.09). In addition, a substantial increase in bleeding complications was observed among participants during the period in which VKA was prolonged (RR 3.44, 95% CI 1.22 to 9.74), and a non–statistically significant reduction in mortality was shown (RR 0.69, 95% CI 0.35 to 1.34). </p> </section> <section id="CD001367-sec-0082"> <h3 class="title" id="CD001367-sec-0082">Overall completeness and applicability of evidence</h3> <p>Only four studies reported mortality during the period from cessation of treatment with VKA in the short duration arm until cessation of treatment in the long duration arm (<a href="./references#CD001367-bbs2-0004" title="KearonC , GentM , HirshJ , WeitzJ , KovacsMJ , AndersonDR , et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. New England Journal of Medicine1999;340(12):901‐7. ">Kearon 1999</a>; <a href="./references#CD001367-bbs2-0005" title="KearonC , GinsbergJS , AndersonDR , KovacsMJ , WellsP , JulianJA , et al. Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor. Journal of Thrombosis and Haemostasis2004;2:743‐9. ">Kearon 2004</a>; <a href="./references#CD001367-bbs2-0006" title="LevineMN , HirshJ , GentM , TurpieAG , WeitzJ , GinsbergJ , et al. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis. Thrombosis and Haemostasis1995;74(2):606‐11. LevineMN , HirshJ , GentM , TurpieAG , WeitzJ , GinsburgJ , et al. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis (DVT). Thrombosis and Haemostasis1993; Vol. 69, issue 6:982. Abstract No 1581. ">Levine 1995</a>; <a href="./references#CD001367-bbs2-0008" title="RidkerP , GoldhaberS , GlynnR . Long‐term, low‐intensity warfarin for the prevention of recurrent venous thromboembolism: the PREVENT trial. Journal of Thrombosis and Haemostasis2003; Vol. 1, issue Suppl 1:Abstract OC001. RidkerPM , GoldhaberSZ , DanielsonE , RosenbergY , EbyCS , DeitcherSR , et al. Long‐term, low‐intensity warfarin therapy for the prevention of recurrent venous thromboembolism. New England Journal of Medicine2003;348(15):1425‐34. ">Ridker 2003</a>). Furthermore, as in all randomized controlled trials, stringent inclusion and exclusion criteria were applied, which means that the current evidence is applicable to patients without increased risk of bleeding. It is likely that absolute bleeding risk is higher in real‐world patients. </p> </section> <section id="CD001367-sec-0083"> <h3 class="title" id="CD001367-sec-0083">Quality of the evidence</h3> <p>See <a href="./full#CD001367-tbl-0001">summary of findings Table for the main comparison</a>. In general, high‐quality evidence suggests that prolonged treatment with VKA reduces the risk for recurrent VTE. Moderate‐quality evidence indicates that prolonged treatment with VKA increases the risk for major bleeding events. We considered the quality of evidence as moderate because of relatively wide confidence intervals around the point estimate; however the point estimates were very similar across all included trials. Moderate‐quality evidence suggests that prolonged treatment with VKA does not reduce mortality significantly, although this was measured in only four studies, one of which reported no deaths (<a href="./references#CD001367-bbs2-0004" title="KearonC , GentM , HirshJ , WeitzJ , KovacsMJ , AndersonDR , et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. New England Journal of Medicine1999;340(12):901‐7. ">Kearon 1999</a>; <a href="./references#CD001367-bbs2-0005" title="KearonC , GinsbergJS , AndersonDR , KovacsMJ , WellsP , JulianJA , et al. Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor. Journal of Thrombosis and Haemostasis2004;2:743‐9. ">Kearon 2004</a>; <a href="./references#CD001367-bbs2-0006" title="LevineMN , HirshJ , GentM , TurpieAG , WeitzJ , GinsbergJ , et al. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis. Thrombosis and Haemostasis1995;74(2):606‐11. LevineMN , HirshJ , GentM , TurpieAG , WeitzJ , GinsburgJ , et al. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis (DVT). Thrombosis and Haemostasis1993; Vol. 69, issue 6:982. Abstract No 1581. ">Levine 1995</a>; <a href="./references#CD001367-bbs2-0008" title="RidkerP , GoldhaberS , GlynnR . Long‐term, low‐intensity warfarin for the prevention of recurrent venous thromboembolism: the PREVENT trial. Journal of Thrombosis and Haemostasis2003; Vol. 1, issue Suppl 1:Abstract OC001. RidkerPM , GoldhaberSZ , DanielsonE , RosenbergY , EbyCS , DeitcherSR , et al. Long‐term, low‐intensity warfarin therapy for the prevention of recurrent venous thromboembolism. New England Journal of Medicine2003;348(15):1425‐34. ">Ridker 2003</a>). </p> </section> <section id="CD001367-sec-0084"> <h3 class="title" id="CD001367-sec-0084">Potential biases in the review process</h3> <p>As two review authors selected and extracted the data independently, the risk of potential bias will be low. Furthermore, we consider it unlikely that we have missed important trials in our search for data because of the extensive literature searches that we conducted. As all studies were investigator‐initiated, we consider it unlikely that trials with a less favourable outcome have not been published. </p> </section> <section id="CD001367-sec-0085"> <h3 class="title" id="CD001367-sec-0085">Agreements and disagreements with other studies or reviews</h3> <p>Although the relative risk reductions remain stable over time elapsed since the index event (RRs varying around 80%), the absolute risk reduction is decreased over time. This can be illustrated by comparing the studies of <a href="./references#CD001367-bbs2-0006" title="LevineMN , HirshJ , GentM , TurpieAG , WeitzJ , GinsbergJ , et al. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis. Thrombosis and Haemostasis1995;74(2):606‐11. LevineMN , HirshJ , GentM , TurpieAG , WeitzJ , GinsburgJ , et al. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis (DVT). Thrombosis and Haemostasis1993; Vol. 69, issue 6:982. Abstract No 1581. ">Levine 1995</a> and <a href="./references#CD001367-bbs2-0009" title="SchulmanS , RhedinA‐S , LindmarkerP , CarlssonA , LarfarsG , NicolP , et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. New England Journal of Medicine1995;332(25):1661‐5. ">Schulman 1995</a> with that of <a href="./references#CD001367-bbs2-0010" title="SchulmanS , GranqvistS , HolmstromM , CarlssonA , LindmarkerP , NicolP , et al. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. New England Journal of Medicine1997;336(6):393‐8. ">Schulman 1997</a>. The studies of <a href="./references#CD001367-bbs2-0006" title="LevineMN , HirshJ , GentM , TurpieAG , WeitzJ , GinsbergJ , et al. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis. Thrombosis and Haemostasis1995;74(2):606‐11. LevineMN , HirshJ , GentM , TurpieAG , WeitzJ , GinsburgJ , et al. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis (DVT). Thrombosis and Haemostasis1993; Vol. 69, issue 6:982. Abstract No 1581. ">Levine 1995</a> and <a href="./references#CD001367-bbs2-0009" title="SchulmanS , RhedinA‐S , LindmarkerP , CarlssonA , LarfarsG , NicolP , et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. New England Journal of Medicine1995;332(25):1661‐5. ">Schulman 1995</a> showed an absolute risk reduction of 8% to 9% achieved with only two to 4.5 months of prolonged treatment in the early phases after the thrombotic event. This is far more efficient than the absolute risk reduction of 18% achieved with 42 months of additional treatment in the study of <a href="./references#CD001367-bbs2-0010" title="SchulmanS , GranqvistS , HolmstromM , CarlssonA , LindmarkerP , NicolP , et al. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. New England Journal of Medicine1997;336(6):393‐8. ">Schulman 1997</a>, six months after the index event. The decline in the incidence of recurrent VTE over time was also observed in the cohort studies of <a href="./references#CD001367-bbs2-0039" title="PrandoniP , LensingAWA , CogoA , CuppiniS , VillaltaS , CartaM , et al. The long‐term clinical course of acute deep venous thrombosis. Annals of Internal Medicine1996;125(1):1‐7. ">Prandoni 1996</a> and in the meta‐analysis of cohort studies and randomized controlled trials performed by <a href="./references#CD001367-bbs2-0044" title="vanDongenCJ , VinkR , HuttenBA , BullerHR , PrinsMH . The incidence of recurrent venous thromboembolism after treatment with vitamin K antagonists in relation to time since first event: a meta‐analysis. Archives of Internal Medicine2003;163(11):1285‐93. ">van Dongen 2003</a>. All of this indicates that a greater amount of effort (ie, years of treatment) will be needed to prevent one recurrent event when the time since the index event is increased. This fact is further complicated by a statistically significant and clinically important increase in bleeding complications, which continued during prolongation. A meta‐analysis of 33 trials and prospective cohort studies showed that absolute bleeding risk among participants with VTE treated for longer than three months with VKA was 2.7 per 100 patient‐years (<a href="./references#CD001367-bbs2-0036" title="LinkinsLA , ChoiPT , DouketisJD . Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta‐analysis. Annals of Internal Medicine2003;139(11):893‐900. ">Linkins 2003</a>). The case fatality rate of major bleeding was 13.4% (9.4% to 17.4%), and the rate of intracranial bleeding was 1.15 (1.14 to 16) per 100 patient‐years (<a href="./references#CD001367-bbs2-0036" title="LinkinsLA , ChoiPT , DouketisJD . Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta‐analysis. Annals of Internal Medicine2003;139(11):893‐900. ">Linkins 2003</a>). For participants who received anticoagulants for longer than three months, the case fatality rate of major bleeding remained high at 9.1% (2.5% to 21.7%), and the rate of intracranial bleeding was 0.65 (0.63 to 0.68) per 100 patient‐years. This adds to a further decrease in net clinical benefit of prolonged treatment with VKA after VTE. </p> <p>The decrease in efficacy and the remaining risk for bleeding during continuing treatment indicate that at some point in time, further continuation is not cost‐effective, nor is it harmful. Given that the case fatality rate of recurrent VTE decreases over time (<a href="./references#CD001367-bbs2-0029" title="CarrierM , LeGalG , WellsPS , RodgerMA . Systematic review: case‐fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism. Annals of Internal Medicine2010;152(9):578‐89. ">Carrier 2010</a>), whereas the risk of major bleeding increases with age, the optimum length of anticoagulant treatment after an episode of VTE remains uncertain (<a href="./references#CD001367-bbs2-0031" title="deJongPG , CoppensM , MiddeldorpS . Duration of anticoagulant therapy for venous thromboembolism: balancing benefits and harms on the long term. British Journal of Haematology2012;158(4):433‐41. ">De Jong 2012</a>; <a href="./references#CD001367-bbs2-0038" title="MiddeldorpS . Duration of anticoagulation for venous thromboembolism. BMJ2011;342:d2758. ">Middeldorp 2011</a>). As patients have different risk profiles, it is likely that this optimal duration will vary. However, on the basis of our results alone, the optimal duration cannot be defined. For this purpose, a decision analytic approach could be used by balancing benefit and risk on the basis of individual risk profiles (<a href="./references#CD001367-bbs2-0040" title="PrinsMH , HuttenBA , KoopmanMMW , BüllerHR . The optimal duration of secondary prevention with oral anticoagulants in patients with venous thromboembolism. A decision analysis. Thrombosis and Haemostasis1999;(Suppl):7‐8. ">Prins 1999a</a>; <a href="./references#CD001367-bbs2-0041" title="PrinsMH , Van denBeltAGM , HuttenBA , BossuytPMM , BüllerHR . Duration of oral anticoagulant treatment in patients with venous thromboembolism and a deficiency of antithrombin, protein C or protein S: a decision analysis. Thrombosis and Haemostasis1999;(Suppl):180. ">Prins 1999b</a>). </p> <p>In conclusion, this meta‐analysis shows that treatment with VKA reduces the risk of recurrent VTE for as long as they are used. However, the absolute risk of recurrent VTE declines over time, although the risk for major bleeding remains. Thus, the efficacy of VKA administration decreases over time from occurrence of the index event. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD001367-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/media/CDSR/CD001367/urn:x-wiley:14651858:media:CD001367:CD001367-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/media/CDSR/CD001367/image_t/tCD001367-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD001367-fig-0001" src="/cdsr/doi/10.1002/14651858.CD001367.pub3/media/CDSR/CD001367/image_n/nCD001367-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/full#CD001367-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/media/CDSR/CD001367/image_n/nCD001367-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001367-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/media/CDSR/CD001367/urn:x-wiley:14651858:media:CD001367:CD001367-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/media/CDSR/CD001367/image_t/tCD001367-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD001367-fig-0002" src="/cdsr/doi/10.1002/14651858.CD001367.pub3/media/CDSR/CD001367/image_n/nCD001367-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/full#CD001367-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/media/CDSR/CD001367/image_n/nCD001367-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001367-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/media/CDSR/CD001367/urn:x-wiley:14651858:media:CD001367:CD001367-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/media/CDSR/CD001367/image_t/tCD001367-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD001367-fig-0003" src="/cdsr/doi/10.1002/14651858.CD001367.pub3/media/CDSR/CD001367/image_n/nCD001367-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/full#CD001367-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/media/CDSR/CD001367/image_n/nCD001367-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001367-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/media/CDSR/CD001367/urn:x-wiley:14651858:media:CD001367:CD001367-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/media/CDSR/CD001367/image_t/tCD001367-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Long vs short, period from cessation of VKA in short arm until VKA cessation in long arm, Outcome 1 Incidence of recurrent VTE." data-id="CD001367-fig-0004" src="/cdsr/doi/10.1002/14651858.CD001367.pub3/media/CDSR/CD001367/image_n/nCD001367-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Long vs short, period from cessation of VKA in short arm until VKA cessation in long arm, Outcome 1 Incidence of recurrent VTE. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/references#CD001367-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/media/CDSR/CD001367/image_n/nCD001367-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001367-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/media/CDSR/CD001367/urn:x-wiley:14651858:media:CD001367:CD001367-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/media/CDSR/CD001367/image_t/tCD001367-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Long vs short, period from cessation of VKA in short arm until VKA cessation in long arm, Outcome 2 Incidence of major bleeding." data-id="CD001367-fig-0005" src="/cdsr/doi/10.1002/14651858.CD001367.pub3/media/CDSR/CD001367/image_n/nCD001367-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Long vs short, period from cessation of VKA in short arm until VKA cessation in long arm, Outcome 2 Incidence of major bleeding. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/references#CD001367-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/media/CDSR/CD001367/image_n/nCD001367-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001367-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/media/CDSR/CD001367/urn:x-wiley:14651858:media:CD001367:CD001367-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/media/CDSR/CD001367/image_t/tCD001367-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Long vs short, period from cessation of VKA in short arm until VKA cessation in long arm, Outcome 3 Mortality." data-id="CD001367-fig-0006" src="/cdsr/doi/10.1002/14651858.CD001367.pub3/media/CDSR/CD001367/image_n/nCD001367-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Long vs short, period from cessation of VKA in short arm until VKA cessation in long arm, Outcome 3 Mortality. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/references#CD001367-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/media/CDSR/CD001367/image_n/nCD001367-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001367-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/media/CDSR/CD001367/urn:x-wiley:14651858:media:CD001367:CD001367-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/media/CDSR/CD001367/image_t/tCD001367-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Long vs short, period after cessation of study medication until end of follow‐up, Outcome 1 Incidence of recurrent VTE." data-id="CD001367-fig-0007" src="/cdsr/doi/10.1002/14651858.CD001367.pub3/media/CDSR/CD001367/image_n/nCD001367-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Long vs short, period after cessation of study medication until end of follow‐up, Outcome 1 Incidence of recurrent VTE. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/references#CD001367-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/media/CDSR/CD001367/image_n/nCD001367-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001367-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/media/CDSR/CD001367/urn:x-wiley:14651858:media:CD001367:CD001367-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/media/CDSR/CD001367/image_t/tCD001367-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Long vs short, period after cessation of study medication until end of follow‐up, Outcome 2 Incidence of major bleeding." data-id="CD001367-fig-0008" src="/cdsr/doi/10.1002/14651858.CD001367.pub3/media/CDSR/CD001367/image_n/nCD001367-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Long vs short, period after cessation of study medication until end of follow‐up, Outcome 2 Incidence of major bleeding. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/references#CD001367-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/media/CDSR/CD001367/image_n/nCD001367-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001367-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/media/CDSR/CD001367/urn:x-wiley:14651858:media:CD001367:CD001367-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/media/CDSR/CD001367/image_t/tCD001367-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Long vs short, period after cessation of study medication until end of follow‐up, Outcome 3 Mortality." data-id="CD001367-fig-0009" src="/cdsr/doi/10.1002/14651858.CD001367.pub3/media/CDSR/CD001367/image_n/nCD001367-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Long vs short, period after cessation of study medication until end of follow‐up, Outcome 3 Mortality. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/references#CD001367-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/media/CDSR/CD001367/image_n/nCD001367-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001367-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/media/CDSR/CD001367/urn:x-wiley:14651858:media:CD001367:CD001367-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/media/CDSR/CD001367/image_t/tCD001367-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Long vs short, entire period after randomization reported in publication, Outcome 1 Incidence of recurrent VTE." data-id="CD001367-fig-0010" src="/cdsr/doi/10.1002/14651858.CD001367.pub3/media/CDSR/CD001367/image_n/nCD001367-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Long vs short, entire period after randomization reported in publication, Outcome 1 Incidence of recurrent VTE. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/references#CD001367-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/media/CDSR/CD001367/image_n/nCD001367-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001367-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/media/CDSR/CD001367/urn:x-wiley:14651858:media:CD001367:CD001367-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/media/CDSR/CD001367/image_t/tCD001367-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Long vs short, entire period after randomization reported in publication, Outcome 2 Incidence of major bleeding." data-id="CD001367-fig-0011" src="/cdsr/doi/10.1002/14651858.CD001367.pub3/media/CDSR/CD001367/image_n/nCD001367-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Long vs short, entire period after randomization reported in publication, Outcome 2 Incidence of major bleeding. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/references#CD001367-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/media/CDSR/CD001367/image_n/nCD001367-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001367-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/media/CDSR/CD001367/urn:x-wiley:14651858:media:CD001367:CD001367-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/media/CDSR/CD001367/image_t/tCD001367-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Long vs short, entire period after randomization reported in publication, Outcome 3 Mortality." data-id="CD001367-fig-0012" src="/cdsr/doi/10.1002/14651858.CD001367.pub3/media/CDSR/CD001367/image_n/nCD001367-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Long vs short, entire period after randomization reported in publication, Outcome 3 Mortality. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/references#CD001367-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/media/CDSR/CD001367/image_n/nCD001367-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001367-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/media/CDSR/CD001367/urn:x-wiley:14651858:media:CD001367:CD001367-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/media/CDSR/CD001367/image_t/tCD001367-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 One month vs 3 months, period from cessation of VKA in short arm until VKA cessation in long arm, Outcome 1 Incidence of recurrent VTE." data-id="CD001367-fig-0013" src="/cdsr/doi/10.1002/14651858.CD001367.pub3/media/CDSR/CD001367/image_n/nCD001367-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 One month vs 3 months, period from cessation of VKA in short arm until VKA cessation in long arm, Outcome 1 Incidence of recurrent VTE. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/references#CD001367-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/media/CDSR/CD001367/image_n/nCD001367-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001367-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/media/CDSR/CD001367/urn:x-wiley:14651858:media:CD001367:CD001367-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/media/CDSR/CD001367/image_t/tCD001367-CMP-005-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Three months vs 6 months, period from cessation of VKA in short arm until VKA cessation in long arm, Outcome 1 Incidence of recurrent VTE." data-id="CD001367-fig-0014" src="/cdsr/doi/10.1002/14651858.CD001367.pub3/media/CDSR/CD001367/image_n/nCD001367-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 Three months vs 6 months, period from cessation of VKA in short arm until VKA cessation in long arm, Outcome 1 Incidence of recurrent VTE. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/references#CD001367-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/media/CDSR/CD001367/image_n/nCD001367-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001367-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/media/CDSR/CD001367/urn:x-wiley:14651858:media:CD001367:CD001367-CMP-006-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/media/CDSR/CD001367/image_t/tCD001367-CMP-006-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Three months vs 12 months, period from cessation of VKA in short arm until VKA cessation in long arm, Outcome 1 Incidence of recurrent VTE." data-id="CD001367-fig-0015" src="/cdsr/doi/10.1002/14651858.CD001367.pub3/media/CDSR/CD001367/image_n/nCD001367-CMP-006-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6 Three months vs 12 months, period from cessation of VKA in short arm until VKA cessation in long arm, Outcome 1 Incidence of recurrent VTE. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/references#CD001367-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/media/CDSR/CD001367/image_n/nCD001367-CMP-006-01.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD001367-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Long‐term or short‐term treatment with vitamin K antagonists for patients with venous thromboembolism</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Long‐term or short‐term treatment with vitamin K antagonists for patients with venous thromboembolism</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with venous thromboembolism<br/> <b>Settings:</b> hospitals and medical centers<br/> <b>Intervention:</b> long‐term treatment with VKA<br/> <b>Comparison:</b> short‐term treatment with VKA </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Short‐term treatment with VKA</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Long‐term treatment with VKA</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Incidence of recurrent VTE</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>88 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>18 per 1000</b> <br/> (10 to 33) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.2</b> <br/> (0.11 to 0.38) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3536<br/> (10 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> <b>high</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Incidence of major bleeding</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>4 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>15 per 1000</b> <br/> (5 to 43) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 3.44</b> <br/> (1.22 to 9.74) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1350<br/> (6 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mortality</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>38 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>26 per 1000</b> <br/> (13 to 51) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.69</b> <br/> (0.35 to 1.34) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1049<br/> (4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (eg, the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence.<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Relatively wide 95% confidence interval around the estimate.<br/> <sup>2</sup>Only 4 studies (including 1 study without events) provided information on this outcome. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Long‐term or short‐term treatment with vitamin K antagonists for patients with venous thromboembolism</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/full#CD001367-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001367-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Long vs short, period from cessation of VKA in short arm until VKA cessation in long arm</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Incidence of recurrent VTE <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3536</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [0.11, 0.38]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Incidence of major bleeding <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1350</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.44 [1.22, 9.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1049</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.69 [0.35, 1.34]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Long vs short, period from cessation of VKA in short arm until VKA cessation in long arm</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/references#CD001367-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001367-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Long vs short, period after cessation of study medication until end of follow‐up</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Incidence of recurrent VTE <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2639</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.28 [0.97, 1.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Incidence of major bleeding <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>179</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>165</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.11 [0.13, 75.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Long vs short, period after cessation of study medication until end of follow‐up</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/references#CD001367-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001367-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Long vs short, entire period after randomization reported in publication</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Incidence of recurrent VTE <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 With extended follow‐up after VKA cessation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3327</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.74 [0.54, 1.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Without extended follow‐up after VKA cessation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>389</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [0.04, 0.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Incidence of major bleeding <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3716</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.60 [1.51, 4.49]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3502</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.66, 1.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Long vs short, entire period after randomization reported in publication</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/references#CD001367-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001367-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">One month vs 3 months, period from cessation of VKA in short arm until VKA cessation in long arm</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Incidence of recurrent VTE <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>379</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.18 [0.04, 0.79]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">One month vs 3 months, period from cessation of VKA in short arm until VKA cessation in long arm</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/references#CD001367-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001367-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Three months vs 6 months, period from cessation of VKA in short arm until VKA cessation in long arm</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Incidence of recurrent VTE <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1113</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [0.02, 0.43]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Three months vs 6 months, period from cessation of VKA in short arm until VKA cessation in long arm</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/references#CD001367-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001367-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Three months vs 12 months, period from cessation of VKA in short arm until VKA cessation in long arm</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Incidence of recurrent VTE <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>610</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.18 [0.07, 0.45]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Three months vs 12 months, period from cessation of VKA in short arm until VKA cessation in long arm</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001367.pub3/references#CD001367-tbl-0007">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD001367.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD001367-note-0004">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD001367-note-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD001367-note-0003">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD001367-note-0002">Hrvatski</a> </li> <li class="section-language"> <a class="" href="pt#CD001367-note-0001">Português</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001367\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001367\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001367\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD001367\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001367\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001367\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001367\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001367\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001367\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD001367\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001367\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001367\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001367\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD001367\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001367\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001367\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001367\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD001367\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=afU96cMv&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD001367.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD001367.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD001367.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD001367.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD001367.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740715726227"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD001367.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740715726231"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD001367.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d8e233ad9f55f',t:'MTc0MDcxNTcyNi4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 